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In Brief
Pain following nerve damage can be
mitigated by cytotoxic natural killer cells
that selectively clear out partially
damaged nerves.
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https://doi.org/10.1016/j.cell.2018.12.022SUMMARY
Sensory axons degenerate following separation from
their cell body, but partial injury to peripheral nerves
may leave the integrity of damaged axons preserved.
We show that an endogenous ligand for the natural
killer (NK) cell receptor NKG2D, Retinoic Acid Early 1
(RAE1), is re-expressed in adult dorsal root ganglion
neurons following peripheral nerve injury, triggering
selective degeneration of injured axons. Infiltration
of cytotoxic NK cells into the sciatic nerve by extrav-
asation occurs within 3 days following crush injury.
Using a combination of genetic cell ablation and
cytokine-antibody complex stimulation, we show
that NK cell function correlates with loss of sensation
due to degeneration of injured afferents and reduced
incidence of post-injury hypersensitivity. This neuro-
immune mechanism of selective NK cell-mediated
degeneration of damaged but intact sensory axons
complements Wallerian degeneration and suggests
the therapeutic potential of modulating NK cell func-
tion to resolve painful neuropathy through the clear-
ance of partially damaged nerves.
INTRODUCTION
Injury to a peripheral nerve results in the destruction of severed
axons distal to the injury site via Wallerian degeneration (Conforti
et al., 2014) thereby facilitating subsequent debris removal by
immune cells (Dekkers et al., 2013). Simultaneously, a genetic
program of axonal outgrowth is then initiated to allow the re-
innervation of targets by healthy nerves (Chandran et al.,
2016), which is in turn supported by the permissive environment716 Cell 176, 716–728, February 7, 2019 ª 2019 The Authors. Publish
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this adaptive response to axonal injury facilitates the phagocy-
tosis of debris and ultimately regeneration of axons, it also
contributes to the maladaptive symptom of neuropathic pain
(Costigan et al., 2009). As a consequence, neuro-immune
signaling mechanisms of hypersensitivity following injury to the
adult peripheral nervous system (PNS) are the subject of intense
research (Chavan et al., 2017).
Axon degeneration is generally regarded as neuron autono-
mous; however, discrepancies in the timing of axon degenera-
tion after injury (Neukomm and Freeman, 2014) and recent
evidence pointing to the role of as-yet-unknown extrinsic factors
in axon fragmentation (Gamage et al., 2017) open up the
possibility of a role for immune cells with cytotoxic action in
the degeneration process itself.
Natural killer (NK) cells are cytotoxic innate lymphoid cells
(ILCs) typically involved in the destruction of tumor or virus-
infected target cells. NK cell activity is coordinated by a bal-
ance of stimulatory and inhibitory signals mediated via a
distinct receptor repertoire (Vivier et al., 2011). One of the
best-characterized activating receptors is NK group 2D
(NKG2D), which is expressed on NK cells and some T cells.
Endogenous ligands for NKG2D are normally absent from
most tissues but are expressed in disease states such as
tumorigenesis and infection (Raulet et al., 2013). NK cells
are found among the immune cells that infiltrate the damaged
nerve following injury in adult animals (Cui et al., 2000), and
the presence of intra-neural NK cells correlates with disease
severity in a form of peripheral neuropathy (Lackowski et al.,
1998). NK cells have previously been shown to be involved
in guanethidine toxicity to sympathetic neurons (Hickey
et al., 1992). In addition, adult murine NK cells are directly
cytotoxic to immature embryonic dorsal root ganglion (DRG)
neurons in vitro (Backstro¨m et al., 2000). However, NK cells
at this stage of primary sensory neuron development appeared by Elsevier Inc.
commons.org/licenses/by/4.0/).
to be immature (Tang et al., 2012), and thus the consequences
of this NK cell interaction for the adult are unclear.
We investigated the response and functional consequences of
NK cell interactions in the context of peripheral nerve injury in the
adult mouse. Our results identify cytotoxic NK cells as a novel
cellular trigger for the specific degeneration of damaged primary
afferent axons that are still connected to their cell bodies in
the injured PNS. Enhancing this NK cell-dependent degenera-
tion mechanism increased clearance of damaged axons result-
ing in lower levels of mechanical hypersensitivity post-injury.
This discovery provides new insight into immune mechanisms
of damaged axon clearance and suggests the therapeutic
potential of interventions that modulate NK cell function.
RESULTS
Activated NK Cells Induce Cytotoxicity in Embryonic
Sensory Neurons by an RAE1-Mediated Mechanism
NK cells are classically activated by the cytokine interleukin
(IL)-2, which primes them for cytotoxic attack by increasing intra-
cellular content of granzyme B (Figure S1A). We examined the
effects of IL-2-stimulated NK cells on DRG neurons acutely iso-
lated from embryonic (E15) and adult mice (cultured less than
24 h in vitro), using freshly isolated, unstimulated splenic NK cells
as a control (Figure S1B). Confirming original reports (Backstro¨m
et al., 2000), embryonic DRG neurons were highly susceptible to
NK cell-mediated cytotoxicity (Figures 1A and 1B). Separating
NK cells and embryonic DRG with a transwell membrane pre-
vented neurite fragmentation (Figure S1C) despite the presence
of nanogram amounts of granzyme B in the culture media (Fig-
ure S1D). In contrast, we found no evidence of cell lysis of
acutely isolated adult DRG neurons by lactate dehydrogenase
(LDH)-release cytotoxicity assay, even at much higher effector-
to-target (E:T) ratios (Figure 1B), although some neurites ap-
peared truncated (Figure 1A).
Time-lapse confocal imaging of DiI-labeled DRG neurons
co-cultured with IL-2-stimulated NK cells expressing yellow fluo-
rescent protein (YFP) revealed that stimulated NK cells were
highly motile, enabling multiple direct cell-cell contacts between
NK cells and sensory neurons. In embryonic DRG, this led to
neurite destruction and cell death (Video S1); however, acutely
cultured adult DRG neurite membranes remained largely intact
(Video S2). NK cell contacts were often synchronous with intra-
cellular Ca2+ events in embryonic DRG neurites (Figures 1C
and 1D; Video S3), leading to neurite fragmentation. While
Ca2+ events were also observed in adult DRG after NK cell
contact (Figures 1C and 1D) and occasionally led to neurite frag-
mentation (Video S4), they occurred at a much lower frequency
than in embryonic neurons (Figure 1D).
Retinoic Acid Early inducible protein 1 (RAE1), encoded by the
Raet1 gene family (a,b,g,d,ε), acts as a membrane-bound ligand
for the activating receptor NKG2D (Cerwenka et al., 2000), which
has previously been implicated in NK cell-mediated lysis of em-
bryonic DRG (Backstro¨m et al., 2003). First, we confirmed that
NK cytotoxicity against embryonic DRG could be attenuated
by an NKG2D receptor blocking antibody (Figure S1E). Using
universal primers, we observed Raet1 transcripts in acutely
dissociated embryonic and adult DRG neurons (Figure 1E), butthey were 17 times more abundant in embryonic DRG relative
to adult DRG when assayed by qPCR (Figure 1F). Western blot
using a pan-RAE1 antibody revealed a band at approximately
40–50 kDa in embryonic but not adult DRG tissue (Figure 1G).
To assess the functional contribution of Raet1 in embryonic
DRG neurons, we selectively knocked down all Raet1 isoforms
using small interfering RNA (siRNA) (Figure 1H), which,
compared to negative control, led to a 20% reduction in NK-
mediated lysis (Figure 1I).
Nerve Injury Drives RAE1 Expression in Adult Sensory
Neurons, Allowing Cytotoxic Attack by Activated
NK Cells
Adult mouse DRG neurons were cultured in a microfluidic cham-
ber for 5 days in vitro. Following exposure to stimulated NK cells,
we saw a 25% loss of neurite coverage relative to freshly isolated
control NK cells (Figures 2A and 2B). Raet1 mRNA was time-
dependently upregulated in adult DRG cultures (Figure 2C),
with corresponding de novo expression of RAE1 protein after
2 days in vitro (Figure 2D). Subsequently, adult DRG neurons
cultured for 2 days displayed over a 10-fold increase in neurite
fragmentation relative to controls in the presence of stimulated
NK cells (Figures 2E and 2F). Transfection of dissociated adult
DRG neurons with Raet1 siRNA prior to culture delayed Raet1
upregulation (Figure 2G) and reduced the ability of stimulated
NK cells to fragment DRG neurites relative to negative control
siRNA (Figures 2H and 2I). We also confirmed that fragmentation
of adult DRG neurites (2 days in vitro) can be reduced by blocking
the NKG2D receptor on NK cells prior to co-culture (Figures S2A
and S2B).
We next asked whether Raet1 upregulation in dissociated DRG
in vitro occurs in injured cells in vivo by cutting the spinal nerve of
the fifth lumbar DRG (L5x) in adult mice (Figure 3A). An injury-
dependent upregulation of Raet1 was revealed by qPCR using
RNA isolated from L5 DRG at 4 and 7 days after L5x injury (Fig-
ure 3B). The difference in Raet1 transcript levels between
ipsilateral and contralateral L5 DRG 7 days after L5x injury was
maintained over the first 24 h in culture (Figure 3C). Injured (L5x)
DRG exhibited 3.5-fold more fragmentation of neurites when
exposed to IL-2-stimulated NK cells (Figures 3F and 3G) than
DRG from uninjured (sham) animals (Figures 3D and 3E), an effect
that was attenuated by prior blocking of NKG2D receptors on NK
cells (Figures S2C and S2D). No difference was seen in the total
DRG cell body area between different groups (Figure S2E) sug-
gesting that the fragmentation was neurite specific.
Cytotoxic NK Cells Respond to Nerve Injury In Vivo and
Target RAE1-Expressing Axons
To characterize the response and function of NK cells in vivo, we
crossedNcr1icremice (Narni-Mancinelli et al., 2011) with reporter
mice that express either YFP (Rosa26eyfp) or the diphtheria toxin
(DTx) receptor (Rosa26dtr; DTR) following Cre-mediated recom-
bination. Ncr1 encodes the NKp46 receptor, which is expressed
on all NK cells, as well as tissue-resident ILCs, including group 1
ILCs (ILC1s) and a subset of group 3 ILCs (NCR1+ ILC3s). This
genetic approach allowed us to identify (Figures S3A and S3B)
or systemically deplete NKp46+ cells in vivo (Figure S3C). We
did not observe YFP-positive NK cells in sciatic nerve in naiveCell 176, 716–728, February 7, 2019 717
Figure 1. Acutely Cultured Embryonic but
Not Adult DRG Neurons Reveal Susceptibil-
ity to NK-Mediated Cytotoxicity by RAE1
(A) Immunolabeling of co-culture (4 h) between
embryonic (top) or adult (bottom) DRG neurons
(b-tubulin, magenta) and either freshly isolated
(control) or IL-2-stimulated natural killer (NK) cells
(NKp46, green). The inset shows a high-magnifi-
cation image of NK cell in contact with embryonic
DRG neurite.
(B) LDH-release cytotoxicity assay of acutely
cultured (1 day in vitro) embryonic (top) and adult
(bottom) DRG at various Effector (NK):Target
(DRG) (E:T) ratios. Matched two-way ANOVA:
embryonic DRG, F(1,10) = 100.01, p < 0.0001);
adult DRG, F(1,10) = 1.25, p = 0.2982). Three
replicate co-cultures for each DRG group.
(C) Still images of in vitro time-lapse confocal Ca2+
imaging of rhodamine 3 AM-loaded embryonic (top)
and adult (bottom) DRG (magenta) co-cultured with
IL-2-stimulated NK cells (green) isolated from adult
male NKp46-YFP mice.
(D) Frequency histogram (30 s time bins) of neurite
Ca2+ events in embryonic (top) and adult (bottom)
DRG during NK co-culture. Cumulative area under
the curve (right). Student’s paired t test; t = 2.290,
p = 0.045. n = 6 fields of view from two repeat
co-cultures per group.
(E) RT-PCR of mRNA transcripts in freshly isolated
splenic NK cells and embryonic and adult DRG.
(F) qRT-PCR shows higher Raet1 mRNA expres-
sion in embryonic compared to adult DRG tissue.
Student’s paired t test; t = 16.16, p < 0.0001. n = 5
mice, or replicates per group.
(G) Western blot of embryonic and adult mouse
DRG tissue (40 mg loading) with pan-RAE1 antibody
and b-actin control. Images are representative of
three independent experiments.
(H) Selective siRNA knockdown reduces RAE1
protein (top) and Raet1mRNA (bottom) expression
in embryonic DRG (2 d culture). Student’s unpaired
t test; t = 9.060, p = 0.0008. n = 3mice, or replicates
per group.
(I) LDH-release cytotoxicity assay of negative con-
trol or Raet1-selective siRNA knockdown embry-
onic DRG. Three replicate co-cultures for each
siRNA group. Matched two-way ANOVA F(1,10) =
133.85, p < 0.0001).
See also Figure S1.mice (data not shown) or sham surgery mice (Figures 3H and 3I).
In contrast, L5x injury led to the marked recruitment of YFP+ NK
cells to the injured sciatic nerve (Figures 3H and 3I) and was
paralleled by an increase in granzyme B content at 7 days
post-injury (Figure 3J), which was significantly reduced by prior
systemic depletion of NK cells (Figure 3K). L5x injury led to a
reduction in the mechanical withdrawal threshold in the ipsilat-
eral hind paw of NKp46-DTRmice treated with PBS (Figure S3D)
that was not affected by prior depletion of NK cells using DTx
(Figure S3D). The sensitivity of the uninjured contralateral paw
remained unaffected by either treatment (Figure S3E).718 Cell 176, 716–728, February 7, 2019Consistent with the effect of nerve transection, crush injury
(Figure 4A) also drove Raet1 expression in ipsilateral DRG as
observed by qPCR (Figure 4B). In situ hybridization revealed
Raet1 transcripts within individual DRG neurons (Figures 4C
and 4D) and across a broad range of cell sizes (Figures S4A
and S4B). RAE1 is known to be controlled by post-transcrip-
tional modification (Raulet et al., 2013); therefore, we performed
western blot on lysates of sciatic nerve and DRG tissues. Crush
injury induced a 45-kDa band in ipsilateral injured sciatic nerve
(Figure 4E), indicating an increase in the glycosylated mature
form of RAE1 (Arapovic et al., 2009) in the nerve, but not in
Figure 2. Raet1Expression IsUpregulated in
Dissociated Adult DRG In Vitro and Confers
NK Cell-Mediated Neurite Fragmentation
(A) Microfluidic culture of adult DRG (5 days in vitro)
exposed to freshly isolated (control) or IL-2-stimu-
lated NK cells (4 h) in the neurite compartment im-
munolabeled with b-tubulin III.
(B) Quantification of DRG neurite density. n = 6–7
regions per microfluidic device, n = 3 devices per
group, two independent experimental repeats.
Student’s unpaired t test; t = 5.448, p < 0.0001.
(C) Raet1 mRNA expression in adult DRG cultures
by qPCR. One-way ANOVA; F (3,15) = 25.94, ***p <
0.0001 with Bonferroni post-test: #p < 0.05, **p <
0.001, ***p < 0.0001; n = 3–6 mice, or replicate
cultures per time point.
(D) RAE1 protein expression in adult DRGcultures 1
and 2 days in vitro (representative of three inde-
pendent experiments). 25 mg protein loading.
(E) Adult DRG culture (2 days in vitro) alone or
co-cultured with IL-2-stimulated NK cells im-
munolabeled with b-tubulin III.
(F) Quantification of DRG neurite fragmentation.
Student’s unpaired t test; t = 12.74, p < 0.0001. n =
6–8 regions per coverslip, n = 3 coverslips per
group, two independent experimental repeats.
(G) siRNAknockdownofRaet1mRNAexpression in
adult DRG in vitro. Two-way ANOVA: effect of
siRNA, F(1,16) = 54.02, ***p < 0.0001 with Bonfer-
roni post-test: **p < 0.001, ***p < 0.0001. n = 3–5
cultures per group.
(H) siRNA-transfected adult DRG culture (2 days
in vitro) alone or co-cultured with IL-2-stimulated
NK cells (4 h) immunolabeled with b-tubulin III.
(I) Quantification of DRG neurite fragmentation.
One-way ANOVA; F (3,201) = 51.16, p < 0.0001 with
Bonferroni post-test: ***p < 0.0001; n = 6–8 regions
per coverslip, n = 6 coverslips per group, two in-
dependent experimental repeats.
See also Figure S2.the DRG (Figure 4F). Chronic tight ligation of the sciatic nerve,
to block axonal transport, revealed RAE1 immunolabeling
within crushed axons proximal to the ligation site (Figures 4G,
4H, and S4B) and greater amounts of RAE1 protein at the
ligation site relative to within the axons proximal to the ligation
(Figure S4C).
Sciatic nerve crush recruited NKp46-YFP cells to the injury
site (Figure S5A) and increased CD45+YFP+ lymphocyte-gated
events within ipsilateral sciatic nerve (Figure S5B) by 30-fold
3 days after injury and a further 50% by day 7 (Figure S5C).Crush injury also raised levels of gran-
zyme B in the sciatic nerve (Figure S5D).
Using two-photon imaging of the sciatic
nerve in vivo 3 days after crush injury,
we observed NKp46-YFP cells ‘‘rolling’’
along the wall of intra-neural blood ves-
sels (Video S5). Within the sciatic nerve
itself, NK cells were highly motile and
displayed multipolar morphology (Video
S6), reminiscent of stimulated NK cellsin vitro. No YFP+ cells were observed by two-photon imaging
in the nerves of sham injured mice (data not shown).
Endogenous NK Response Attenuates Post-injury
Sensitivity
Depletion of NK cells by DTx treatment in NKp46-DTRmice (Fig-
ure S5E) reduced NKp46+ cell infiltration (Figures S5F and S5G)
and granzyme B content in the crushed nerves (Figure S5H).
Control (PBS-treated) NKp46-DTRmice were almost completely
insensitive to pinprick stimulation of the hind paw until a relativelyCell 176, 716–728, February 7, 2019 719
Figure 3. Peripheral Nerve Injury Regulates
Raet1 Expression and Injured Sensory Neu-
rons Show IncreasedNeurite Fragmentation
by Stimulated NK Cells
(A) Schematic diagram of spinal nerve transection
injury site in relation to lumbar DRGs (L3, L4,
and L5)
(B) Raet1 mRNA expression in ipsilateral L5 DRG
after spinal nerve transection relative to contra-
lateral DRG by qPCR. Two-way ANOVA: effect
of injury, F(1,12) = 121.25, p = 0001; effect of
time, F(1,12) = 5.08, p = 0.0438. Bonferroni post-
test, ipsi versus contra: 4 days, t = 6.193, ***p <
0.001; 7 days, t = 9.380, ***p < 0.001. n = 4
samples per time point, n = 2 mice DRG pooled
per sample.
(C) qPCR shows injury-related increase in Raet1
mRNA expression in adult DRG (1 day in vitro).
Student’s unpaired t test, t = 4.994, p = 0.0075.
n = 3 mice, 3 replicate cultures.
(D) Immunolabeling (b-tubulin III) of cultured L5
DRG (1 day in vitro) isolated 7 d after sham
surgery co-cultured (4 h) with either freshly iso-
lated (control) or IL-2-stimulated NK cells.
(E) Quantification of sham DRG neurite frag-
mentation. One-way ANOVA: F(2,61) = 7.171 p =
0.0016. Bonferroni post-test: DRG only versus
control NK, t = 0.4349, nonsignificant (ns) p >
0.05; control NK versus IL-2-stimulated NK, t =
3.221 **p < 0.01; DRG only versus IL-2-stimu-
lated NK, t = 3.180, **p < 0.01.
(F) Immunolabeling (b-tubulin III) of cultured L5
DRG (1 day in vitro) isolated 7 days after L5
spinal nerve transection co-cultured (4 h) with
either freshly isolated (control) or IL-2-stimulated
NK cells.
(G) Quantification of L5x DRG neurite fragmen-
tation. One-way ANOVA: F(2,56) = 95.92, p <
0.0001. Bonferroni post-test: DRG only versus
control NK, t = 0.5204, ns p > 0.05; control NK
versus IL-2-stimulated NK, t = 11.45, ***p <
0.001; DRG only versus IL-2-stimulated NK, ***t =
11.86, p < 0.001. n = 6–8 regions per coverslip,
n = 6 coverslips per group, two independent
experimental repeats.
(H) Sciatic nerve tissue sections from adult male
NKp46-YFP mice 7 days after L5 spinal nerve
transection injury immunolabeled with anti-GFP
(NKp46, green). Arrows indicate NK cells in
sciatic nerve.
(I) Quantification of YFP+ events within lympho-
cyte gate from whole sciatic nerve homogenates.
One-way ANOVA: F(3,16) = 10.61, p = 0.0004.
Bonferroni post-test: L5x ipsi versus contra,
t = 4.710, **p < 0.01; sham ipsi versus contra, t =
0.053, ns p > 0.05; L5x ipsi versus sham ipsi, t =
4.526, **p < 0.01 (n = 5 mice for each group).
(J) ELISA quantification of granzyme B content in wild-type whole sciatic nerve after L5x injury. Student’s paired two-tailed t test: 7 days ipsi versus contra
L5x, t = 8.088, p = 0.0002 (n = 7 mice).
(K) ELISA quantification of granzyme B content in NKp46-DTR mice whole sciatic nerve after L5x injury. Student’s unpaired one-tailed t test: 7 days PBS
versus DTx L5x ipsi, t = 11.03, p < 0.0001 (n = 5 mice per treatment).
See also Figures S2 and S3.rapid heel-to-toe pattern of recovery beginning in the second
week after injury (Figures S5I and S5J, PBS) consistent with
axon regeneration through the foot (Latremoliere et al., 2018).720 Cell 176, 716–728, February 7, 2019In contrast, NK depleted mice showed an early and persistent
sensitivity to pinprick stimulation (Figure S5I, DTx) and displayed
an anatomically broad pattern of responses to stimulation across
Figure 4. Sciatic Nerve Crush Increases
RAE1 in Peripheral Nerve Axons
(A) Schematic diagram of sciatic nerve crush injury
site in relation to lumbar DRGs (L3, L4, and L5).
(B)Raet1mRNAexpression in ipsilateral L3–5 DRG
3 and 7 days after surgery by qPCR. Two-way
ANOVA: effect of injury, F(1,8) = 180.95, p <
0.0001; effect of time, F(1,8) = 8.04, p = 0.0220.
Bonferroni post-test: 3 days, t = 7.507, ***p <
0.001; 7 days, t = 11.52, ***p < 0.001. n = 3mice per
surgery per time point.
(C) In situ hybridization with Raet1 probe (red) in L4
DRG immunolabeled for NeuN (blue) 6 days after
partial sciatic nerve crush injury. Scale bar, 50 mm.
(D) Distribution of Raet1 in situ spots in L4 DRG ipsi
and contralateral to sciatic crush. Kolmogorov-
Smirnov (KS) test: ***p < 0.0001, KS D-value
0.2297. n = 3 mice, n = 3 sections per ipsi and
contralateral DRG per mouse.
(E) (Top) Pan-RAE1 western blot of sciatic nerve
tissue (40 mg protein loading) 3 days after sciatic
nerve crush or sham surgery. Neuronal cadherin
control is shown. (Bottom) Relative expression of
RAE1 protein in ipsilateral versus contralateral
sciatic nerves 3 and 7 days after sham or crush
surgery. One-way ANOVA, 3 days: F(3,16) = 8.505,
p = 0.0013. Bonferroni post-test: sham ipsi versus
contra, t = 0.2025, ns p > 0.05; crush ipsi versus
contra, t = 3.678, *p < 0.05; ipsi sham versus crush,
t = 4.438, **p < 0.01. One-way ANOVA, 7 days:
F(3,16) = 5.119, p = 0.0113. Bonferroni post-test:
sham ipsi versus contra, t = 0.1438, ns p > 0.05;
crush ipsi versus contra, t = 3.342, *p < 0.05; ipsi
sham versus crush, t = 3.043, *p < 0.05 (n = 5 mice
per surgery group per time point).
(F) (Top) Pan-RAE1 western blot of DRG (L3–5)
tissue (40 mg protein loading) 3 days after sciatic
nerve crush or sham surgery. Neuronal cadherin
control. (Bottom) Relative expression of RAE1
protein in ipsilateral versus contralateral DRG 3
and 7 days after sham or crush surgery. One-way
ANOVA: 3 days, F(3,16) = 0.438, p = 0.7288;
7 days, F(3,20) = 0.053, p = 0.983 (n = 5–6 mice per
surgery group per time point).
(G) Composite images of RAE1 immunolabeling in
full-length contralateral and ipsilateral sciatic
nerves taken from three individual mice 3 days
after tight sciatic nerve ligation. Arrow, ligation site;
arrowhead, proximal to ligation.
(H) Maximum projection images of RAE1 (green)
co-localization with axonal marker b-tubulin III
(magenta) in sciatic nerve 3 days after tight ligation.
Scale bars, 50 mm.
See also Figures S3 and S4.the hind paw prior to full recovery (Figure S5J, DTx), indicative of
sporadic intact innervation throughout the paw.
Stimulated NK Cells Degenerate Partially Injured
Sensory Axons
To replicate the stimulation of NK cells by IL-2 in vitro, we
treated mice systemically with an IL-2/anti-IL-2 monoclonal
(S4B6) antibody complex (Votavova et al., 2014), leading to
enrichment of NKp46+DX5+ and CD3+CD8+ lymphocyte popu-
lations (Boyman et al., 2006) (Figure 5A). To determine whetherNK cells could selectively degenerate partially injured axons,
we delivered a reproducible partial sciatic nerve crush (see
STAR Methods). Control animals displayed residual pinprick
sensitivity 1 day after crush, followed by a rapid functional re-
covery to over 60% of maximum by day 6 (Figure 5B, immuno-
globulin G [IgG]) and reached full recovery by day 15 (Figure 5C,
IgG), suggesting that a proportion of fibers were not fully axo-
tomized by the initial crush injury. In contrast, animals treated
with the IL-2 complex showed a significant acute reduction in
the pinprick response 6 days after crush and 1 day after the finalCell 176, 716–728, February 7, 2019 721
Figure 5. IL-2/Anti-IL-2 Antibody Complex Treatment Triggers NK Cell-Dependent Acute Sensory Loss after Partial Sciatic Nerve Crush
(A) Peripheral blood sampled 16 days post-injury in IL-2 complex or IgG control mice. NKp46+DX5+ NK cells (U = 15.00, p = 0.0019); CD3+CD8+ T cells (t = 15.78,
p < 0.0001); CD3+CD4+ T cells (t = 9.719, p < 0.0001). Mann-Whitney or Student’s unpaired t test was used.
(B) Daily pinprick response. Male wild-type C57BL/6 mice received partial crush of the sciatic nerve on day 0 followed by daily injection of IL-2 complex or
IgG control (i.p.) for 4 consecutive days (arrows). Two-way ANOVA was used. Effect of treatment: F(1,315) = 20.69, p < 0.0001. Bonferroni post-test **p < 0.01
(t = 3.784), ***p < 0.001 (t = 4.741).
(C) Heatmap showing mean sensitivity to pinprick along the lateral hind paw. Note the broad loss of sensitivity at day 6 in IL-2-complex-treated mice.
(D) Area under the curvemeasurements in IL-2-complex-treated and IgG control mice. Days 1–4: p = 0.9513, t = 0.06181; days 5–10: ***p = 0.0083, t = 2.916; days
11–15: p = 0.4354, t = 0.7951. Student’s unpaired t test was used.
(E) Effect of IL-2 complex treatment on NKp46-YFP+ cell infiltration to sciatic nerve 6 days after partial crush injury. Sciatic nerve sections (14 mm) were im-
munolabeled with anti-GFP and b-tubulin III antibodies. Scale bars, 100 mm. Arrows indicate individual YFP+ cells.
(legend continued on next page)
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injection (Figures 5B, 5C, and 5D, IL-2 complex). This was par-
alleled by a 10-fold increase in the numbers of NKp46-YFP+
cells in the injured nerve at the crush site and distal to the injury,
but not proximal to the crush site in IL-2-complex-treated mice
(Figures 5E and 5F). Treated mice also displayed enlargement
of the spleen (Figure 5G). Contralateral nerves did not display
any infiltration of NKp46-YFP+ cells (Figures 5E and 5F) and
contralateral paws remained fully sensitive to pinprick
throughout the experiment (data not shown).
Flow analysis of peripheral blood after recovery (day 16)
confirmed depletion of NKp46+DX5+ NK cells by an anti-
NK1.1 antibody in wild-type mice (Figure 5H) and by DTx in
NKp46-DTR but not wild-type mice (Figure S5K). No difference
was observed in CD3+CD8+ T cell populations with either
method of depletion (Figures 5H and S5L). Anti-NK1.1 anti-
body was also sufficient to deplete the majority of NKp46-
YFP+ cells from the peripheral blood of NKp46-YFP mice
(Figure 5I). In isotype-control-treated mice, IL-2 complex treat-
ment again resulted in acute loss of the pinprick response (Fig-
ures 5J–5L, Isotype), whereas NK cell-depleted mice main-
tained a constant level of ‘‘retained’’ sensitivity throughout
the paw (Figures 5J–5L, Anti-NK1.1). Similar results were ob-
tained in DTx-treated wild-type and NKp46-DTR mice (Figures
S5M and S5N).
IL-2 complex-stimulated wild-type mice treated with the anti-
NKG2D blocking antibody, which did not deplete NK cells (Fig-
ures S6A), reduced specific NKG2D labeling on peripheral blood
NK cells by >60% (Figures S6B and S6C), and attenuated the
sensory loss after IL-2 complex treatment compared to iso-
type-control-treated mice (Figures S6D and S6E).
The density of b-tubulin III-labeled axon fibers in the sciatic
nerve 6 days after partial crush was reduced within the crush
site and distal region by IL-2 complex treatment (Figures 6A
and 6B, insets b and c) but not the proximal nerve region (Figures
6A and 6B, inset a). Labeling for microtubule-associated protein
stathmin 2 (STMN2), expressed by injured DRG neurons (Cho
et al., 2013), was observed throughout the crushed nerve and
was also reduced by IL-2 complex treatment at the crush site
and distal regions relative to IgG control (Figures 6C and 6D,
regions b and c). STMN2 also co-localized with RAE1 immuno-
labeling at the injury site (Figures S4B).
To assess axon integrity directly, we employed transmission
electron microscopy of the sciatic nerve injury site 6 days after(F) Quantification of NKp46-YFP+ cells per square millimeter in images of different
p < 0.0001; effect of region, F(3,16) = 23.73, p < 0.0001. Bonferroni post-tests: cru
region, per mouse, per treatment.
(G) Photograph of spleens isolated from mice 1 day after final injection of IgG or
(H) Peripheral blood sampled 16 days post-injury in IL-2-complex-treated wil
NKp46+DX5+ NK cells (t = 15.37, ***p < 0.0001), CD3+CD8+ T cells (U = 22.00, p =
was used.
(I) Loss of NKp46-YFP+ cells from peripheral blood in anti-NK1.1-antibody-treate
(J) Wild-type mice received either anti-NK1.1 to deplete NK cells or isotype contro
treated with IL-2 antibody complex (arrows). Two-way ANOVA. Effect of antibo
(t = 4.542).
(K) Heatmap showing mean sensitivity to pinprick along the lateral hind paw. No
(L) Area under the curve measurements in isotype control and anti-NK1.1-treated
5–10: t = 2.390, p = 0.0295; days 11–15: t = 1.040, p = 0.3130). Student’s unpair
See also Figure S5.partial sciatic nerve crush (Figure 6E). Myelinated axons, likely
to conduct the sensory response to pinprick (Ziegler et al.,
1999), were categorized according to their myelin and axoplasm
integrity (Figure 6F). Injured nerves from IL-2-complex-treated
mice contained significantly more degenerated myelinated
axons than IgG-only controls (Figures 6E and 6G, degenerated)
and less abnormal axon-Schwann cell units (Figure 6G,
abnormal), suggesting that such axon fibers—a feature of clini-
cally relevant peripheral neuropathies (Sander et al., 2000)—
may be targeted for degeneration by activated NK cells. Deple-
tion of NK cells with an anti-NK1.1 antibody prior to IL-2 complex
stimulation prevented these changes (Figure 6G).
Clearance of Partially Damaged Axons Alleviates Pain
Hypersensitivity after Injury
We next compared the effects of partial and full crush models in
the absence of immunemodulation (Figures 7A–7C). After recov-
ery of pinprick sensation, pawwithdrawal thresholds were signif-
icantly lower (i.e., more mechanically sensitive) in mice with pre-
vious partial crush injury relative to those that received a full
crush, a difference that lasted at least 30 days after the original
injury (Figure 7D). IL-2 complex treatment after partial crush re-
sulted in higher hind-paw mechanical thresholds compared to
control (IgG) animals at days 15–16 after injury (Figure 7E), an
effect that was prevented by either prior depletion of NK cells
(Figure 7F) or blockade of the NKG2D-RAE1 interaction (Fig-
ure S6F). Combined data revealed a positive correlation between
post-crush pinprick sensitivity and the resulting mechanical
sensitivity of the injured limb (Figure 7G).
Finally, we examined the effect of expression of the RAE1
ligand in sensory neurons in the absence of injury. We used a
Trpv1-driven Cre mouse line to conditionally overexpress
Raet1 in a population of thermal nociceptive DRG neurons (Fig-
ure S7A). These mice displayed an impaired ability to sense
noxious heat but demonstrated no change in mechanical thresh-
olds compared to littermates and wild-type controls (Figures
S7B and S7C).
DISCUSSION
RAE1 Function and Regulation in the Injured Nerve
NKG2D ligands such as RAE1 can be expressed by prolifer-
ating tumor cells or at times of cell stress such as during DNAregions of the nerve. Two-way ANOVA: effect of IL-2 complex, F(1,16) = 56.31,
sh, t = 8.062; distal, t = 6.414 ***p < 0.001. ns, not significant. n = 3 sections per
IL-2 complex.
d-type mice, which received either anti-NK1.1 antibody or isotype control.
0.1473), and CD3+CD4+ T cells (t = 3.035, p = 0.0079). Student’s unpaired t test
d mice. Student’s unpaired t test, t = 15.51, ***p = 0.0001.
l antibody followed by partial crush of the sciatic nerve on day 0. All mice were
dy depletion: F(1,240) = 21.21, p < 0.0001. Bonferroni post-test, ***p < 0.001
te the broad loss of sensitivity at day 6 in isotype control mice.
mice following IL-2 complex treatment. days 1–4: t = 0.1508, p = 0.8815; days
ed t test was used.
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Figure 6. IL-2/Anti-IL2 Antibody Complex after Partial Crush Results in Loss of Myelinated Fibers in Sciatic Nerve
(A) b-tubulin III immunolabeling of full-length ipsilateral sciatic nerve sections (14 mm) 6 days after partial crush in mice treated with IgG (top) and IL-2 complex
(bottom). Insets a, b, c represent proximal, crush site, and distal regions, respectively.
(B) High-magnification images of b-tubulin III immunofluorescence from insets in (A). Scale bars, 50 mm. (Right) Quantification of b-tubulin III fluorescence density
of 9,000 mm2 area of proximal, crush site, and proximal regions. Two-way ANOVA: effect of region: F(2,64) = 57.39 (p < 0.0001). Effect of IL-2 complex treatment:
F(1,64) = 7.36 (p = 0.0106). Bonferroni post-test *p < 0.05 (t = 2.558), ***p < 0.001 (t = 3.981). (n = 5 mice per treatment, 3–4 sections per mouse per region, two
experimental repeats).
(C) Stathmin 2 immunolabeling of full-length ipsilateral sciatic nerve sections 6 days after partial crush in mice treated with IgG (top) and IL-2 complex
(bottom).
(legend continued on next page)
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Figure 7. NK Cell Stimulation Post-injury
Rescues Long-Term Mechanical Hypersen-
sitivity after Partial Nerve Crush
(A) Effect of partial or full crush of the sciatic nerve
on daily pinprick responses. Wild-type mice
received either partial crush or full crush on day 0.
Two-way ANOVA. Effect of crush: F(1,165) =
186.25, p < 0.0001. Bonferroni post-test **p < 0.01
(t = 3.68, 4.07), ***p < 0.001 (t = 4.19–6.14).
(B) Area under the curve measurements showing
cumulative difference in pinprick sensitivity
between partial and fully crushed sciatic nerve.
Student’s unpaired t test: days 1–4, t = 4.176, p =
0.0.0015; days 5–10, t = 4.674, p = 0.0007; days
11–15, t = 2.502, p = 0.0294.
(C) Heatmap showing mean sensitivity to pinprick
along the lateral hind paw.
(D) Mechanical sensitivity thresholds of the ipsi-
lateral hind paw after partial or full crush injury at
day 16 (t = 4.550 p = 0.0008, unpaired t test) and
30 days (U = 3.50, p = 0.0149, unpaired Mann-
Whitney test) after injury.
(E) Mechanical sensitivity thresholds of ipsilateral
hind paw 16 days after partial crush injury in mice
treatedwith IL-2 complex or IgG control (U = 32.00,
p = 0.0370, Mann-Whitney test).
(F) Mechanical sensitivity thresholds of ipsilateral
hind paw 15 days after partial crush injury and
IL-2/anti-IL-2 complex treatment in mice that
received anti-NK1.1 antibody or isotype control
(U = 7.000, p = 0.0049, Mann-Whitney test).
(G) Mechanical sensitivity outcomes in the injured
limb correlated with the cumulative pinprick
sensitivity (area under curve, days 5–10) during the
peak effect of treatment (Spearman’s correlation:
r = 0.5958, p < 0.0001).
See also Figure S7.damage or tissue injury (Raulet et al., 2013). Although periph-
eral nerve injury increased Raet1 transcription in the DRG,
i.e., in cell bodies of sensory neurons, changes in RAE1
protein were detected specifically within the injured sciatic
nerve. This suggests that RAE1 protein is either transported an-(D) High-magnification images of STMN2 immunofluorescence from insets in (B). Scale bars, 50 mm. (Rig
Two-way ANOVA: effect of region: F(2,58) = 39.95 (p < 0.0001). Effect of IL-2 complex treatment: F(1,58) = 1
(t = 3.346), ***p < 0.001 (t = 3.846). (n = 5 mice per treatment, 3–4 sections per mouse per region.
(E) Transmission electron micrographs of cross-sections of ipsilateral sciatic nerve in IgG, IL-2 complex, and a
crush injury. Scale bars, 10 mm.
(F) Higher-magnification TEM images showing examples of ‘‘normally’’ myelinated, ‘‘abnormally’’ myelinate
Scale bars, 2 mm (black) and 5 mm (white).
(G) Quantification of normal myelinated, abnormal myelinated, and degenerated fiber classifications in the d
ANOVA with Dunn’s multiple comparison test. Kruskal-Wallis statistic: normal (26.50), abnormal (25.03), an
0.001. n = 10 fields of view per nerve section, n = 3 mice per treatment.
See also Figure S6.terogradely along the axon or that Raet1
mRNA is translated locally in injured sen-
sory axons (Willis et al., 2005). The
anatomical restriction of RAE1 protein
to the peripheral axons of injured sensory
neurons suggests that the functional
interaction between NKG2D andneuronal RAE1 occurs at the peripheral injury site, which likely
protects the cell body from potentially catastrophic attack from
NK cells soon after injury (Tandrup et al., 2000). Neurons may
also restrict degeneration to the axon by actively inhibiting
apoptosis in the cell body (Cusack et al., 2013).ht) Quantification of STMN2 fluorescence density.
0.24 (**p = 0.0033). Bonferroni post-test **p < 0.01
nti-NK1.1 antibody treated mice 6 days after partial
d, and degenerated axons (denoted by asterisks).
ifferent treatment groups. Kruskal-Wallis one-way
d degenerated (51.81),*p < 0.05, *p < 0.01, ***p <
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Recruitment and Cytotoxicity of Injury-Responsive
NK Cells
Using two photon imaging in vivo, we observed YFP-expressing
NK cells rolling and attaching to the blood vessel wall within the
injured nerve, suggesting that NK cells enter the nerve via extrav-
asation from the blood, a process known to be chemokine
dependent (Sheikh et al., 2004). Consistent with that possibility,
the chemokines CCL2, CCL3, and CX3CL1 are all highly ex-
pressed after peripheral nerve injury (Ren and Dubner, 2010)
with the corresponding chemokine receptors, CCR2, CCR5,
and CX3CR1 expressed by NK cells (Loux et al., 2010). Within
the nerve tissue itself, YFP-expressing NK cells displayed a
‘‘stop-go’’ behavior, previously observed by live imaging in other
tissues (Garrod et al., 2007), allowing NK cells to effectively sur-
vey the damaged nerve for injured axons.
In injured sciatic nerve, we detected elevated levels of gran-
zyme B, a serine protease that is essential for NK cell cytotoxic
functions (Voskoboinik et al., 2015). Systemic depletion of NK
cells reduced levels of granzyme B detected 7 days after nerve
injury, suggesting that NK cells are functional in the injured pe-
ripheral nerve. In vitro, NK cell contact was followed within
minutes by intra-axonal Ca2+ flux and subsequent neurite frag-
mentation. This time course is well within the time frame of im-
mune synapse formation between NK and target cells (Lopez
et al., 2013) and suggests that targeted delivery of cytotoxic
enzymes to the injured axon is sufficient to trigger neurite degen-
eration (Wang et al., 2012). Further studies will be required to
determine whether these NK cell-derived degenerative signals
cooperate with the known components of ‘‘intrinsic’’ axon
degeneration distal to the injury site, including SARM1 and cal-
pain activation (Gerdts et al., 2016).
NK Cell-Mediated Neurodegeneration
Wallerian degeneration in the sciatic nerve can be induced by
multiple types of crush injury (Bridge et al., 1994). In our study,
a conventional forceps crush injury was sufficient to cause
the total loss of pinprick sensation from 1 day after nerve injury
in all mice, with recovery of evoked sensation beginning more
than 1 week later (Latremoliere et al., 2018). However, in NK
cell-depleted mice a significant restoration of pinprick response
was observed just days following complete crush. This latent
sensitivity is in keeping with early electron microscopic studies
of Wallerian degeneration, which report that some fibers may
survive more than 2 or 3 days and well beyond an early period
of axonal degeneration (Dyck and Hopkins, 1972). Our results
therefore suggest that certain sciatic nerve crush injuries may
not be sufficient to axotomize all fibers and that degeneration
of the surviving axons requires an additional extrinsic trigger.
The rapid return of pinprick sensation we observed in the first
week after partial crush in control animals is consistent with the
functional recovery present in the ‘‘moderate’’ injury model of
optic nerve crush (Duvdevani et al., 1990). The increase in
b-tubulin III-labeling we observed distal to the partial crush site
is further consistent with either sprouting or axon swelling typical
after a contusion injury, whereby axons that do not fragment can
survive intact long term (Williams et al., 2014). Our electron
microscopy data suggest that many axons do indeed survive
in the sciatic nerve after partial crush.726 Cell 176, 716–728, February 7, 2019IL-2/anti-IL-2 monoclonal (S4B6) antibody complex treatment
has been successfully used to expand NK cells in vivo for the
treatment of cancer (Votavova et al., 2014). This strategy re-
vealed an acute period of NK cell-dependent sensory loss, which
correlated with a lower density of STMN2-expressing axons as
well as a reduction in abnormally myelinated axons and a corre-
sponding increase in the number of degenerated myelinated
axons in sciatic nerve cross-sections. These results suggest
that IL-2-activated NK cells further remove damaged axons
that would otherwise have been spared. Critically, the simulta-
neous recovery of pinprick sensation in both groups of mice
(by day 15) suggests that successfully regenerating axon fibers
are not among those targeted by NK cells.
Consequences for Post-injury Sensation
After recovery of pinprick responses, partially nerve crushed
mice showed hypersensitivity tomechanical stimulation, a surro-
gate marker of chronic neuropathic pain. The mechanical hyper-
sensitivity that appears 2 weeks after injury may be due to
damaged but functionally intact sensory axons, as well as other
damaged axons that have not re-innervated their targets but
remain within the nerve (Xie et al., 2017). We therefore hypothe-
size that the active targeting of NK cells to remove partially
injured fibers early after injury helps to leave the nerve uncontam-
inated by previously damaged axons and thus enable successful
regeneration without the aberrant sensation and pain often
associated with nerve injury (Costigan et al., 2009).
Overexpression of Raet1 in TRPV1-lineage sensory neurons
(Mishra et al., 2011) in otherwise naive mice was sufficient for a
loss of sensation specific to noxious heat. This points to the
potential for neuronal stressors initiating a detrimental action of
NK cells on previously uninjured peripheral nerves (Hickey
et al., 1992) by upregulation of NK cell ligands (Backstro¨m
et al., 2007; Greene et al., 2016). NK cells may therefore be a
therapeutic target in multiple die-back peripheral neuropathies
that are often co-morbid with metabolic stress in patients with
neuropathic pain (Bennett et al., 2014).
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EXPERIMENTAL MODEL AND SUBJECT DETAILS
Animals
All procedures were approved by the Institutional Animal Care and Use Committee (IACUC) at Seoul National University (Approval
number: SNU-121011-1). Adult male and pregnant dam wild-type C57BL/6 mice were purchased from Dae Han Bio Link (Taconic,
Korea). Rosa26eyfp (RRID:IMSR_JAX:006148), Rosa26dtr (RRID:IMSR_JAX:007900) and Trpv1cre mice which express Cre recombi-
nase from the endogenous Trpv1 locus (RRID:IMSR_JAX:017769), were purchased from Jackson Laboratories (USA). Ncr1icre
mice (RRID:MGI:5308422), containing cre-recombinase inserted by homologous recombination at the 30 end of the Ncr1 (Nkp46)
gene (Narni-Mancinelli et al., 2011), were a kind gift from Dr Eric Vivier. Rosa26raet1e mice (RRID: MGI:5823988), expressing a floxede2 Cell 176, 716–728.e1–e10, February 7, 2019
stop site upstream of theRaet1e gene inserted at the Rosa26 locus (Morvan et al., 2017) were a kind gift fromDr Lewis Lanier. All mice
are originally on a C57BL/6 background except Trpv1cre, which are on a mixed B6 and 129 background, and Rosa26eyfp mice which
were backcrossed onto the C57BL/6 background for at least 10 generations. All mice were maintained as homozygous stocks in
a specific pathogen free (SPF) facility and transferred to a conventional room at least one week before experiments. Double hetero-
zygote Nrc1icre/wt;rosa26eyfp/wtmice (abbreviated to NKp46-YFP) and Nrc1icre/wt;rosa26dtr/wtmice (abbreviated to NKp46-DTR) were
bred from single crosses. Trpv1cre/wt;rosa26raet1e/wt mice (abbreviated to TrpV1-Rae1) and Trpv1cre/wt;rosa26wt/wt mice (littermates)
were the product of crosses between Trpv1cre/cre and rosa26raet1e/wt mating pairs. Mice were maintained on a 12 h:12 h light/dark
cycle (lights on at 8:00 a.m.), housed 4-6 mice per cage on wood chip bedding with nestlets and provided with standard
laboratory feed and water ad libitum. DRG neurons and NK cells were prepared from male C57BL/6 mice (6-8 weeks); embryonic
DRG neurons were prepared from embryos on day 15 in utero (E15) removed from euthanized female C57BL/6 mice. Nerve injury
experiments were performed on male mice age 7-9 weeks old of indicated genotype. Animals were killed in accordance with
Schedule 1 of the UK Animals (Scientific Procedures) Act 1986 by inhalation of a rising lethal concentration of isoflurane followed
by decapitation for tissue culture, or a rising lethal concentration of carbon dioxide at the end of experiments.
METHOD DETAILS
NK cell depletion
NKp46-DTR mice were treated with diphtheria toxin (DTx; 100 ng) or sterile PBS vehicle (100 ml) intravenously by retro-orbital injec-
tion. Under isoflurane anesthesia (3% induction, 1%–2% maintenance in 100% O2) an ophthalmic solution (0.5% proparacaine,
Alcon, Belgium) was applied to the eye as a local anesthetic. An insulin syringe (0.3ml, BD Biosciences) was inserted bevel-down
behind the eye into the retro-orbital sinus and 100 ml slowly injected. Injections were alternated between eyes. Injections were
administered blind to the content of the syringe starting one day prior to surgery and continuing every four to five days for the duration
of the study. All mice were blood sampled at the end of experiments for depletion efficiency check by flow cytometry.
For antibody depletion of NK cells, wild-type C57BL/6 mice were injected with 100 mg of LEAF purified anti-mouse NK1.1 (clone
PK136) (Biolegend, cat no. 108712, RRID:AB_313399) or LEAF purified rat IgG2a,k isotype control (cloneMOPC-173) (Biolegend, cat
no. 400224, RRID:AB_326472) intravenously by retro-orbital injection one day before nerve injury.
For blocking of NKG2D in vivo adult male C57BL/6 mice received a total of 200 mg LEAF purified anti-mouse CD314 (NKG2D) (CX5
clone) (Biolegend, cat no. 130204, RRID:AB_1227715) or LEAF purified rat IgG1k isotype control (Clone RTK2071) (BioLegend, cat
no. 400414, RRID:AB_326520) via retroorbital injection (i.v.) over 4 days: 50 ug (Day 0), 50 ug (Day 2), 100 ug (Day 4).
L5 spinal nerve transection (L5x)
Male mice age 7-9 weeks old were placed under isoflurane inhalation, the dorsal lumbar region was shaved, treated with an iodine
solution (Potadine) and a unilateral incision made parallel to the L6 vertebrate. Under a x20 dissection microscope illuminated by a
cold light source themusculature was parted by blunt forceps dissection to reveal the L6 transverse process, which was then cut and
removed. The L5 spinal nerve, which runs immediately below the L6 process, was carefully freed of connective tissue and cut with
fine spring scissors; 1 mm of the nerve was removed to prevent nerve regeneration. The wound was irrigated with sterile saline and
closed in two layers with 6-0 silk sutures (Ailee, Korea) and 9mm skin clips (MikRon Precision, CA, USA) Mice were placed in a warm,
darkened cage to recover from surgery.
Sciatic nerve crush
Adult male mice (7-9 weeks old) received a single unilateral crush injury to the sciatic nerve (Bridge et al., 1994). Briefly, under iso-
flurane anesthesia the right thigh was shaved and iodine treated and an incision was made mid-thing length. The sciatic nerve
exposed as it emerges from the sciatic foramen by parting the muscle with blunt forceps dissection. The nerve was carefully freed
of connective tissue and fully crushed for 15 s using fine, mirror-finished forceps (No 5, Dumont, Fine Science Tools, Germany). The
wound was closed in two layers with two sutures of the overlying muscle facia and a single skin clip to close. Complete crush of
the sciatic nerve was deemed successful by a sensory score of zero using the pinprick assay on the day following surgery; any
mice with a pinprick response less than 24 h after surgery were excluded from analysis.
For partial crush the sciatic nerve an ultra-fine hemostat (Cat no. 13020-12, Fine Science Tools, Germany) was fitted with a custom
spacer created from two layers of aluminum foil (15 mm thick) to create a gap 30 mm thick when fully closed. The sciatic nerve was
carefully freed of connective tissue and placed between spacers on the hemostat (2-3 mm from the tip) by gently lifting the nerve
using a fire-polished glassed rod. The hemostat was then closed on the first locking position and held for 15 s before careful release
of the nerve. Full sciatic nerve crush was performed in the sameway except no spacer was used. Thewoundwas closed in two layers
with two sutures of the overlying muscle facia and a single skin clip. Mice were recovered in a warm, darkened cage. All tools were
autoclaved prior to surgery and strict aseptic technique was maintained throughout.
IL-2/anti-IL-2 antibody complex treatment
Recombinant mouse interleukin-2 (Cat no. 212-12, lot no. 0608108; Peprotech, Rocky Hill, NJ, USA) was prepared as a stock at
0.1 mg/ml in PBS (without carrier protein) and stored at 4C for up to one week, according to the manufacturer’s instructions. OnCell 176, 716–728.e1–e10, February 7, 2019 e3
the day of treatment, IL-2 (1.5 mg per mouse) was pre-mixed with anti-mouse IL-2 monoclonal antibody (50 mg per mouse) (S4B6-1
clone) (BioXCell; RRID:AB_1107705) and incubated at room temperature for 15 min. The bound cytokine/antibody complex was
further diluted in sterile PBS to a total volume in 500 ml and injected intraperitoneally. Injections were given once daily (evening
time) for four days. For control experiments, mice were injected with an equal amount of rat IgG2a isotype peptide (clone 2A3)
(BioXCell; RRID:AB_1107769). The efficacy of the IL-2 antibody complex treatment was confirmed by enlargement of the spleen
compared to PBS injected mice one day after the final injection (Boyman et al., 2006).
Behavioral testing
All sensory testing was performed between the hours of 09.00 and 18.00 in an isolated room maintained at 22 ± 2C and 50 ± 10%
humidity. For mechanical threshold (von Frey filament) testing, mice were brought from the animal colony and placed in transparent
plastic boxes on a metal mesh floor with 5x5 mm holes (Ugo Basile, Italy). The mice were then habituated for at least 30 min prior
to testing. To assess mechanical sensitivity, the withdrawal threshold of the affected hind paw was measured using a series of
von Frey filaments (0.20, 0.40, 0.70, 1.6, 3.9, 5.9, 9.8 and 13.7 mN, Stoelting, Wood Dale, IL, USA; equivalent in grams to 0.02,
0.04, 0.07, 0.16, 0.40, 0.60, 1.0 and 1.4). The 50% withdrawal threshold was determined using the ‘up-down’ method and
calculated using Up-Down Reader software (Gonzalez-Cano et al., 2018). A brisk hind paw lift or flinch in response to von Frey fila-
ment stimulation was regarded as awithdrawal response. The 0.4 g filament was the first stimulus to be used, and, when awithdrawal
response was obtained, the next weaker filament was used. This process was repeated until no response was obtained, at which
time the next stronger filament was administered. All behavioral testing was performed by an investigator who was blind to the
treatment of the mice.
Pinprick sensory recovery testing was performed as previously described (Latremoliere et al., 2018) with slight modification. Mice
were habituated on an elevated mesh in separate compartments. The lateral side of the affected hind paw was separated into five
regions from the toe to the heel and stimulated with a stainless steel Austerlitz insect pin (Size 000, FST, Germany). A sensory
response was confirmed by rapid lifting or flinching of the paw. The number of responses to two consecutive pin applications to
the skin was recorded per region providing a score out of 10. Responses due to direct movement of the paw or hind limb (indicative
of extraterritorial proprioception) were excluded. Testing was carried out daily (09.00 – 14.00) until full sensory recovery (score of 10)
was observed for all mice.
For hot plate testing, mice were placed on a metallic plate heated at 49C within an acrylic container (Bioseb, France), and the
latency to flinching, licking one of the hind paws or jumping wasmeasured. A cut-off time of 60 s was used to minimize the possibility
of cutaneous tissue damage.
DRG culture
Adult and embryonic DRG were rapidly dissected on ice-cold Ca2+- and Mg2+-free Hank’s Buffer Saline Solution (HBSS, Welgene)
(including 20mM HEPES) and digested 30-60 min in collagenase A (1 mg/ml) and dispase II (2.4U/ml) (Roche, Switzerland) at 37C.
Additional digestion was carried out for 5-7 min in trypsin (0.25%) and stopped with a trypsin inhibitor (2.5 mg/ml) (Sigma, T9003) in
PBS followed by washing in Dubellco’s Modified Eagle Medium (GIBCO, Life Technologies) containing 10% serum (GIBCO, Life
Technologies). DRG were dissociated by trituration with a fire-polished glassed pipette in DMEM containing DNase I (125 U/ml)
and centrifuged at 200 g on a layer of Bovine Serum Albumin (15%BSA solution; Sigma) before re-suspension in neurobasal medium
(GIBCO, Life Technologies) with B27 supplement, L-glutamine (1 mM), penicillin (100 U/ml) and streptomycin (100 U/ml) supple-
mented with nerve growth factor (NGF 2.5S) at 50 ng/ml. Adult DRG (103 cells) and embryonic DRG (8x103 cells) were plated on
10 mm diameter glass coverslips, glass bottom dishes or 96 well flat-bottom culture plates (Nunclon, Thermo Scientific) previously
coated with poly-D-lysine (10 mg/ml) and laminin (10 mg/ml) (Sigma).
For injured DRG experiments, ipsilateral L5 DRGwere rapidly dissected on ice-cold HBSS from adult mice 7 days after L5x or sham
surgery, pooled (n = 3 DRG per group) and dissociated to a single cell suspension as above. DRG were then seeded onto
poly-D-lysine and laminin-coated glass bottom dishes (103 cells per dish) and cultured overnight in neurobasal medium containing
NGF (50 ng/ml).
For microfluidic co-cultures, DRG neurons isolated from adult mice (as above) were suspended in neurobasal medium and
seeded (104 cells) into the somal reservoir of a microfluidic device (XonaMicrofluidics, CA, USA) previously coated with poly-D-lysine
(10 mg/ml) and laminin (10 mg/ml) (Sigma). NGF (100 ng/ml) was added to themedia in the neurite reservoir. Neurons were cultured for
5 days during which neurites grew along 3 mm x 500 mm channels connected to the neurite reservoir.
NK cell isolation and stimulation in vitro
NK cells were prepared from adult male C57BL/5 mouse spleens (6-8 weeks old). Spleens were homogenized by sequentially pass-
ing through 70 mm and 40 mm cell strainers (Falcon, BD Biosciences). Red blood cells were lysed by incubation for 2 min in ACK lysis
buffer (in mM: 150 NH4Cl, 10 KHCO3, 0.1 Na2EDTA, pH 7.3). Single-cell suspensions were then passed through nylon wool columns
(Polysciences, Warrington, PA) for the depletion of adherent populations, consisting of B cells and macrophages. Eluted cells were
re-suspended in 0.01 M phosphate buffered saline (PBS) plus 2 mM EDTA and 2% FBS. NK cells were enriched using a magnetic
associated cell sorting (MACS) method in combination with a negative selection protocol (Mouse NK cell isolation Kit II, cat no.
130-096-892, Miltenyi Biotech GmbH, Germany) according to the manufacturer’s instructions. Briefly, cell suspensions weree4 Cell 176, 716–728.e1–e10, February 7, 2019
sequentially incubated at 4Cwith a cocktail of biotin-conjugatedmonoclonal antibodies against non-NK cells followed by anti-biotin
microbeads. The cell suspension was then passed through an LS column placed in a magnetic field (MidiMACS Separator, Miltenyi
Biotech GmbH). Bead-conjugated non-NK cells remained in the columns while non-labeled NK cells passed through in the eluent.
Enriched NK cell were either used directly (control) or stimulated with recombinant murine interleukin (IL)-2 (Cat no. 212-12, lot no.
0608108; Peprotech, Rocky Hill, NJ, USA) at 1000 U/ml for two days before use in experiments. NK cells were cultured at 2x106 cells
per ml in RPMI 1640 medium (GIBCO, Life Technologies) supplemented with fetal bovine serum (FBS) (10%) and penicillin/
streptomycin (100 U/ml) in 96-well U-bottomed (Falcon, BD Biosciences) plates for 48 h. The purity of NK cells (NKp46+DX5+) in
the eluent was checked by flow cytometry to be consistently above 90%. The cells were then harvested and used as effector cells
in co-culture and cytotoxicity experiments.
DRG - NK co-cultures
Control or IL-2 stimulated NK cells were harvested, washed in RPMI and re-suspended in neurobasal media. DRGwerewashed once
in neurobasal media (NGF-free) and NK were added to the neurite compartment (5x105 cells) for microfluidic cultures or seeded
(2.5x105 cells) directly over the DRG for glass coverslip cultures, and co-cultured for 4 h at 37C and 5% CO2. Co-cultures were
carefully washed once in warm HBSS and fixed with 2%–4% PFA in 0.01M PBS (pH 7.4) for 30 min at RT, followed by washing in
PBS (3 3 10 mins) at storage at 4C prior to immunolabeling for b-tubulin III and NKp46 (see Immunofluorescence).
For transwell experiments, glass coverslip cultures of DRGwere transferred to a 24-well plate in 500 ml Neurobasal media. NK cells
(2.5x105 per well) were seeded onto 6.5 mm diameter polycarbonate transwell membrane inserts with 0.4 mm pore size (Corning)
and incubated for 4 h at 37C and 5% CO2 before removal of the membrane and fixation as above.
For antibody blockade of NKG2D function in vitro, NK cells were incubated with 30 mg/ml of LEAF purified anti-mouse CD314
(NKG2D) (CX5 clone) (Biolegend, cat no. 130204. RRID:AB_1227715) or LEAF purified rat IgG1 isotype control (Clone RTK2071)
(Biolegend, cat no. 400414. RRID:AB_326520) for 15 min at room temperature (2.5x106 NK cells per ml) before addition to target
DRG neurons.
LDH-release cytotoxicity
Effector NK cells were assayed for cytotoxicity against DRG neuron targets bymeasuring the release of lactate dehydrogenase (LDH)
into the culture medium using an LDH Cytotoxicity Assay Kit (Thermo Scientific Pierce, IL, US). Control or IL-2 stimulated NK cells
were harvested, washed in RPMI and added to DRG cultures in 96 well plates (Nunclon, Thermo Scientific) in neurobasal medium
at various ratios and cultured for 4 h before sampling of media supernatant which was assayed for LDH activity according to
manufacturer’s instructions. Absorbance values were acquired on a microplate spectrophotometer (BioTek Instruments, VT, US).
Each ratio was determined in triplicate. Specific cytotoxicity was calculated as follows: % cytotoxicity = [(experimental release -
spontaneous release)/(maximum release - spontaneous release)] x 100. The optimum number of target cells (DRG neurons) for
maximum LDH release detection was determined prior to experiments (8x103 embryonic DRG neurons; 103 adult DRG neurons).
Live confocal imaging
Adult or embryonic mouse DRG (103 and 8x103 neurons, respectively) cultured for one day on PDL and laminin-coated glass-bottom
Petri dishes were fluorescently labeled with Vybrant DiI (Molecular Probes, cat no. V-22886) or loaded with the Ca2+ indicator rhoda-
mine 3-AM (Molecular Probes, cat no. R10145) according to the manufacturer’s instructions. NK cells previously isolated from
NKp46-YFP mice and stimulated IL-2 (1000U/ml) for 48 h were suspended in neurobasal media and seeded onto the coverslip
(2.5x105 cells per dish). Dishes containing DRG-NK co-cultures were immediately transferred to a confocal microscope (LSM
700, Zeiss) and maintained in a humidified atmosphere at 37C and 5% CO2 (Live Cell Instruments, Seoul Korea). A time series of
single z section images (5123 512) were acquired using a multitrack setting (488 nm and 555 nm fluorescence emission and differ-
ential interference contrast (DIC) bright-field) at 30-60 s intervals and multiple positions under the control of Definite Focus. Images
were acquired up to 3h and exported as a sequential time-lapse in AVI format.
In vivo two photon sciatic nerve imaging
Male NKp46-YFP mice (8-9 weeks old) received unilateral sciatic nerve crush or sham surgery. On day 3 mice were anaesthetized
with pentobarbital (80 mg/kg, i.p.) supplemented with 20 mg/kg immediately prior to recording. Some mice additionally received
Dextran-Texas red (neutral 40,000 m.w.) (Molecular Probes) given via retro-orbital injection (100 ml, 10 mg/ml) to visualize the vascu-
lature and confirm maintenance of blood flow during recording. The sciatic nerve was re-exposed and bathed in sterile saline. Mice
were placed on a warm pad maintained at 35C for the duration of the imaging. The sciatic nerve was carefully lifted with two curved
glass rods held via a micromanipulator at both distal sides of the exposed nerve to mechanically isolate the nerve from the body and
minimize the breathing-induced motion artifacts. A W plan-Apochromat 20X water immersion lens was lowered to the nerve surface
1-2 mm distal from the crush site to identify the blood vessels and YFP-positive cells. After the Ti-sapphire laser (Chameleon,
COHERENT) was tuned to thewavelength of 900 nm for excitation of both YFP and Texas Red, 3D time-lapse imagingwas performed
using a laser scanning confocal microscope (LSM 7MP, Zeiss) as follow: 10243 512 pixels per a single image, 0.79 ms of pixel dwell,
2 mm x 25 sections per a z stack (total 50 mm depth) at 30 s interval. The two-photon laser power was compensated according to the
depth across 5 - 8% of total power. The image was rendered into 2D video using imaging software (Zeiss Efficient Navigation 2012).Cell 176, 716–728.e1–e10, February 7, 2019 e5
DRG small interference RNA gene knockdown
Acute isolated adult or E15 embryonic DRGwere transfected with siRNA by electroporation (Neon, Invitrogen) according to the man-
ufacturer’s instructions. Briefly, single cell suspensions of DRG were suspended in an electroporation medium containing siRNA
oligonucleotide and drawn into a tip containing a gold-plated electrode (5x104 cells per 10ml). Tips of cells were placed into a
tube containing electrolytic buffer, electroporated (1500V, 20ms) and immediately ejected into penicillin/streptomycin-free
neurobasal media containing 50 ng/ml NGF and cultured for 48h at 37C, 5% CO2 until assessment of assessment of knockdown
or functional experiments. Prior to experiments transfection efficiency was optimized by electroporation of DRG with a cDNA
plasmid encoding green fluorescent protein (GFP) (0.5mg) and examination of GFP fluorescence after two days in culture. Two
siRNA oligonucleotides per target were tested for knockdown efficiency by real time PCR; siRNA oligos that reduced mRNA
expression by more than 70% compared to a negative control siRNA oligonucleotide were used for functional experiments. Gapdh
siRNA oligonucleotides (10nM) (Silencer Select, Ambion, Life Technologies, cat no. 4390849) were used as a positive control.
siRNA oligonucleotides used for cytotoxicity assays were:Raet1a-e (10nM) (sense) 50-CAAUGGUUACCCACAUUUAtt-30; (antisense)
50-UAAAUGUGGGUAACCAUUGgt-30 (Silencer Select, Ambion, Life Technologies, cat no. 4390771, ID s234333); Negative control
#1 (10nM) (Silencer Select, Ambion, Life Technologies, cat no. 4390843).
Peripheral blood lymphocyte isolation
Systemic depletion of NK cell was confirmed at the end of experiments in a sample of peripheral blood obtained by retro-orbital
bleed. Briefly, under isoflurane anesthesia a 15ml glass Pasteur pipette was inserted into the retro-orbital sinus and gently twisted
to disrupt the orbital venous plexus. 50-100 ml of blood was removed by capillary action and ejected into heparin-coated tubes (Idexx
Laboratories, USA). Blood samples were diluted with an equal volume of serum-free RPMI, floated on top of a lymphocyte separation
medium (Lympholyte Mammal, Cedarlane Labs, Canada) and centrifuged at 1000 g for 20 min with a slow acceleration gradient.
Peripheral blood mononuclear cells were collected from the monolayer, washed in RPMI and suspended in FACS buffer (5%
FBS, 0.002% NaN3 in 0.01M PBS, pH 7.4) for flow cytometry analysis.
Flow cytometry
For surface labeling cell suspensionswere transferred to 5mL round bottom tubes and Fc receptors were blockedwith unconjugated
rat anti-mouse CD16/CD32 (clone 2.4G2)monoclonal antibody (1:100; BDBiosciences, cat no. 553142. RRID:AB_394657) for 15min
at 4C and labeled with a combination of fluorescently-conjugated anti-mouse primary antibodies for 30 min at 4C. After washing
with FACS buffer cell suspensions were run on a four-color flow cytometer (FACSCalibur, BD Biosciences) and gated populations
analyzed with Cell Quest software (BD Biosciences). Lymphocytes were initially gated according to the FSC-SSC scatter profile;
cell populations were identified by fluorescence gating compared to unlabeled or IgG controls. Antibodies used were PE rat anti-
mouse NKp46 (clone 29A1.4) monoclonal antibody (1:200; eBioscience, cat no. 12-3351. RRID:AB_1210743), APC rat anti-mouse
CD49b (clone DX5) monoclonal antibody (1:500; eBioscience, cat no. 17-5971. RRID:AB_469484), FITC Armenian hamster anti-
mouse CD3e (clone 145-2C11) monoclonal antibody (1:1000; eBioscience, cat no. 11-0031. RRID:AB_464881), APC rat anti-mouse
CD45 (clone 30-F11) monoclonal antibody (1:200; eBioscience, cat no. 17-0451. RRID:AB_469393), PE rat anti-mouse CD4 (clone
GK1.5) monoclonal antibody (1:1000; eBioscience, cat no. 12-0041. RRID:AB_465507), APC rat anti-mouse CD8a (clone 53-6.7)
monoclonal antibody (1:1000; eBioscience, cat no. 17-0081. RRID:AB_469335). For confirmation of NKG2D block in vivomean spe-
cific fluorescence labeling with PE anti-mouse CD314 (NKG2D) (CX5 clone) (Biolegend, cat no. 130207. RRID:AB_1227713) was
calculated by subtracting the mean fluorescence intensity obtained with PE rat IgG1k isotype control (Clone MOPC-21) (BD Biosci-
ences, cat no. 554680. RRID:AB_395506). Titers of flow cytometry antibodies were determined prior to experiments by comparison
to equivalent concentrations of fluorescence-conjugated IgG isotype controls. Percentages of peripheral blood cell populations were
calculated from 20,000 gated lymphocyte events.
Intracellular staining
For intracellular labeling of granzyme B cell suspensions were washed in RPMI, resuspended in FACS buffer and Fc receptors were
blocked for 15 min at 4C. Cells then underwent fixation and permeablisation in BD Cytofix/Cytoperm buffer (BD Biosciences, cat
no. 554714) for 20 min at 4C followed by labeling with PE rat anti-mouse granzyme B (clone NGZB) monoclonal antibody (1:100;
eBioscience, cat no. 12-8898. RRID:AB_10853811) or PE rat IgG2a isotype control (1:100; eBioscience, cat no. 12-4321. RRI-
D:AB_470052) for 30 min at 4C and washing in BD Perm/Wash buffer.
Preparation of sciatic nerve suspensions and flow cytometry
For flow cytometry analysis of NK cells present in sciatic nerve, NKp46-YFP mice were deeply anaesthetized with pentobarbital
(100mg/kg, i.p.) followed by trans-cardiac perfusion with PBS (0.01 M, pH 7.4) at various time points after peripheral nerve injury
to remove peripheral blood from the circulation. Bilateral sciatic nerves were rapidly removed to ice-cold Ca2+- and Mg2+-free
HBSS (Welgene) (including 20mM HEPES) and cut into 1-2 mm pieces. Tissues were transferred to 15 mL tubes and centrifuged
at 500 g for 5 min. HBSS was replaced with collagenase A (1 mg/ml) and dispase II (2.4 U/ml) (Roche, Switzerland) and incubated
90 min at 37C with frequent gentle agitation. Additional digestion was carried out for 5 min in trypsin (0.25%) and stopped with a
trypsin inhibitor (2.5 mg/ml) (Sigma, T9003) in PBS followed by washing in RPMI containing 10% serum (GIBCO, Life Technologies).e6 Cell 176, 716–728.e1–e10, February 7, 2019
Nerves were dissociated by trituration with a fire-polished glassed pipette in RPMI containing DNase I (125 U/ml), passed through
a 30 mm separation filter to remove debris (Miltenyi) and resuspended in FACS buffer in 5 mL round bottom tubes. Prior to sciatic
nerve flow cytometry, CD45+ lymphocyte and NKp46-YFP cell gating was set on peripheral blood lymphocytes from wild-type
and NKp46-YFP mice. Sciatic nerve samples were run on the slow setting until the total event count was less than 50 per second,
or gated events were less than one per 5 s. NK cells were identified by lymphocyte FSC-SSC scatter profile and YFP fluorescence;
in some experiments total lymphocytes were additionally labeled with an APC-conjugated anti-mouse CD45 antibody (1:400;
eBioscience, cat no. 17-0451. RRID:AB_469393).
Tissue preparation
At specific time points after nerve injury or sham surgery, mice were deeply anaesthetised with pentobarbital (100 mg/kg, i.p.)
followed by exsanguination by trans-cardiac perfusion with PBS (0.01 M, pH 7.4) containing heparin (500 U/L). Whole DRG (lumbar
L3-L5) and full length sciatic nerve (spinal nerves to peripheral trifurcation) tissues were dissected and collected in sample tubes
which were immediately frozen on liquid nitrogen and stored at 70C for later molecular analysis. For immunohistochemistry
PBS perfusion was followed by a paraformaldehyde fixative (4% PFA, 0.2% picric acid in 0.1M PBS, pH 7.4). Sciatic nerves were
post-fixed up to 24h and cryoprotected in sucrose solution (30% sucrose in 0.01M PBS, pH 7.4) at 4C. Fixed sciatic nerve tissues
were embedded in frozen section compound (Optimal Cutting Temperature, Leica), sectioned on a cryostat (14mm) and thaw-
mounted on glass microscope slides (Superfrost Plus, Fischer Scientific).
Immunofluorescence
After washing in PBS (33 10 mins) cells and tissues were blocked and permeabilized in 10% normal donkey serum (NDS, Jackson
ImmunoResearch) and 0.1%–0.3% Triton X-100 in PBS for 1h at RT. Primary antibodies were applied in 1% NDS, 0.01%–0.03%
Triton X-100 in PBS and incubated overnight at 4C in a humidified chamber. Primary antibodies used were: Rabbit anti-b-tubulin
III (1:400-500; Sigma, cat no. T2200. RRID:AB_262133), goat anti-NKp46 (1:200; R&D Systems, cat no. AF2225. RRID:AB_355192),
rabbit anti-STMN2 (1:500; Novus Biologicals, cat no. NBP1-49461. RRID:AB_10011569), goat anti-mouse pan-RAE1 (1:40; R&D sys-
tems, cat no. AF1136. RRID:AB_2238016), chicken anti-GFP (1:2000; Abcam, cat no. ab13970. RRID:AB_300798) and chicken
anti-NeuN (1:400; Merck Millipore, cat no. ABN91. RRID:AB_11205760). Fluorescence-conjugated secondary antibodies were incu-
bated in 1% NDS, 0.1%–0.3% Triton X-100 in PBS for 1h at RT the dark. Secondary antibodies used were: Alexa Fluor 647 donkey
anti-rabbit (1:200; Molecular Probes, cat no. A31573. RRID:AB_2536183), Alexa Fluor 488 donkey anti-goat (1:200; Jackson
ImmunoResearch, cat no. 705-545-003. RRID:AB_2340428), Alexa Fluor 488 goat anti-chicken (1:200; Molecular Probes, cat no.
A-11039. RRID:AB_142924), Biotin goat anti-chicken (1:200; Vector, cat no. BA-9010. RRID:AB_2336114) and pacific blue strepta-
vidin (1:200; Thermo Scientific, cat no. S11222). For RAE1 double labeling with b-tubulin III and STMN2, primary and secondary
labeling was performed sequentially (RAE1 first) for each antibody with a repeat blocking stage between. Fluorescence images
(1024 3 1024) were acquired sequentially on a laser-scanning confocal microscope (LSM 700 Zeiss) with Zen 2012 software
(v8.1 SP1, Zeiss). Coverslips were imaged in a single z section. Tissue sections were mounted with DAPI-containing hard-setting
aqueous mounting medium (Vectorsheild, Vector Laboratories) and imaged as a stack of 4-5 3 2mm z sections and exported as a
maximum intensity projection TIFF.
In situ hybridization
Male C57BL/6 mice (aged 7-8 weeks) received a unilateral sciatic nerve partial crush injury as described. On day 6 post-injury mice
were perfused with 0.01M PBS followed by 4% PFA in 0.1M PBS buffer. Bilateral lumbar DRG were dissected and post-fixed over-
night at 4C followed by cryopreservation in 30% sucrose in PBS for 5 days at 4C. DRG tissues were embedded in OCT compound,
10 mm sections were cut on a cryostat and thaw-mounted to Superfrost slides and stored at80C. Sections from the ipsilateral and
contralateral DRG of eachmouse were mounted on the same slide. In situ hybridization (ISH) was performed with RNA Scope 2.5 HD
assay (Red) (322350) according to the manufacturer’s instructions (Advanced Cell Diagnostics, Bio-Techne). Slides were allowed to
reach room temperature (RT) then washed once in PBS to remove OCT compound followed by hydrogen peroxide treatment 10 min
at RT. Sections the underwent antigen retrieval by submerging in boiling retrieval buffer for 2 min followed by wash in distilled water.
After ethanol (100%) treatment sections were treated with Protease Plus reagent (ACD) for 30 min at 40C in a humidified chamber.
Slides were then incubated with probe Mm-Raet1 (448121; targets all Raet1 isoforms) or positive and negative control probes for 2 h
at 40C. Following thorough washes sections were incubated with six rounds of amplification reagents followed by signal develop-
ment with fast red. Sections were then processed for NeuN immunohistochemistry. Briefly, sections were blocked with 10% normal
goat serum, 0.3% triton-x in 0.01M PBS (1 h, RT) followed by incubation with a chicken anti-NeuN antibody (1:400) overnight at 4C.
The next day sections underwent sequential labeling with biotinylated goat anti-chicken antibody (1:200) and pacific blue-conjugated
streptavidin (1:200).
Transmission electron microscopy
On day 6 after partial crush mice were perfused with 0.1 M sodium cacodylate trihydrate and 0.1 M sucrose buffer, pH 7.3, followed
by 4% paraformaldehyde and 2.5% glutaraldehyde (EM grade) in 0.1 M sodium cacodylate buffer, pH 7.3. Bilateral sciatic nerves
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were carefully trimmed down in a proximal direction toward the crush site. Samples were washed 1x 20 min with 50mM glycine in
0.1M SC buffer with rotation followed by 1x 10-20 min with 0.1M SC buffer. Staining was performed with 1.5% potassium ferrocy-
anide + 1.5% osmium in 0.1M SC buffer for 4hrs at 4C with vigorous rotation followed by wash 3x 10 min and 1x30 min with MQ
water. Finally, sampled were stained with 0.5% uranyl acetate overnight at 4C and washed 3x 60 min with water. The dehydration
and resin infiltration was performed in the Leica AMW microwave. Briefly, this consisted of 1-2min steps in each 30%, 50%, 70%,
90%, 95% and 100% ethanol at 37C with constant 25W power, followed by 100% acetone with 3x changes over 5 min. Resin infil-
tration was performed with 3:1, 1:1, 1:3 acetone:epoxy resin (Ducrupan) in 3 min steps at 37C and 10W. Samples were then taken
through 5x changes 100% resin over 80mins at 45C, 12W, with the final resin step performed at 50C. Nerves were then embedded
in fresh Durcupan resin in flat dish molds at 60C for 48 hr. Semithin (500nm) and ultrathin sections (90nm) were taken approximately
400 mm in from the proximal end of the crush site of each nerve. Semithin sections were transferred to glass slides and stained with
Toludine blue. Ultrathins were transferred to formvar coated 50mesh copper grids and post-stained for 5mins with lead citrate. Grids
were imaged at 120 kV in a FEI Tecnai 12 TEM using a Gatan OneView camera.
Myelinated axons were classified as follows: Normal - Uniform compact myelin sheath with continuous axoplasm; Abnormal -
Axons surrounded by myelin abnormalities including tomaculae, myelin out-foldings and recurrent myelin loops (Goebbels et al.,
2012); Degenerated - Absent or vacuous axoplasm surrounded by myelin debris. The number of each axon category per field of
view (1471 mm2) was counted by an observer blind to the treatment group.
Western blot
Tissues and cells were homogenized in RIPA buffer (Millipore, Cat# 20-188) containing protease inhibitor cocktail (Sigma, P8340) and
phosphatase inhibitor cocktail (Gendepot, Cat# P3200). Cultured cells were washedwith warmedHBSS and collected in protein lysis
buffer by scraping; frozen tissues were disrupted either in a Minilys bead homogenizer (Precellys, Bertin, France) or glass grinder.
Homogenized samples were then sonicated (3 3 10 s, 25% amplitude) on ice and then spun at high speed (10,000 g) for 10 min
at 4C after 40min incubation on ice and pellet discarded. An equal volume of 5X SDS sample buffer was added to the sample lysates
which were boiled at 9C heat block for 5min. Protein content was determined by colorimetric assay (Lowry, BioRad). Equal amounts
of protein (25-40 mg) and protein size markers were separated by SDS-polyacrylamide gel electrophoresis (5% stacking gel, 10%
resolving gel) followed by transfer to a PVDF membrane. Membranes were blocked in a 5% skimmed milk solution containing Tris
buffered saline and 0.1% tween-20 (TBS-T) at room temperature for 1h and subsequently incubated with goat anti-mouse Pan-RAE1
antibody (1:500; R&D systems, cat no. AF1136. RRID:AB_2238016) overnight at 4C in blocking solution. Blots were washed with
TBS-T (3 3 10 min) and then incubated with anti-goat HRP-conjugated secondary antibody (1:10,000; Santa Cruz, cat no. sc-
2020. RRID:AB_631728) for 1 h at room temperature. After washing with TBS-T blots were developed by application of western
ECL substrate (BioRad, cat no. 1705061) according to the manufacturer’s instructions and images of sequential exposure times
were acquired digitally (ChemiDoc, BioRad). Blots were then stripped with stripping buffer at 50C for 30 min followed by TBS-T
washing and subsequently incubated with mouse anti-beta-actin (1:10,000; Sigma, cat no. A5441. RRID:AB_476744) and rabbit
anti-N-cadherin (1:10,000; Millipore, cat no. 04-1126. RRID:AB_1977064) in blocking solution. Goat anti-mouse polyclonal
(1:10.000; Komabiotech, cat no. K-0211589. RRID:AB_2636911) or goat anti-rabbit (1:10,000; Santa Cruz, cat no. sc-2004.
RRID:AB_631746) HRP-conjugated secondary antibodies were applied, respectively, and then exposed after ECL treatment. Embry-
onic mouse head tissue was used as positive control for RAE1.
For RAE1 expression in tightly ligated sciatic nerve 7 days after injury, mice were perfused with PBS and ipsilateral sciatic nerve
was cut into two 5 mm sections: one flanking the crush site and one proximal to the spinal nerves. Tissues were snap frozen in liquid
nitrogen and stored at 80C for later analysis.
Enzyme-linked immunosorbant assay (ELISA)
GranzymeB content of sciatic nerveswas determined by ELISA according to themanufacturer’s instructions (DuoSet, R&DSystems,
cat no. DY1865). Briefly, 96 well plates were coated with capture antibody overnight at RT, washed and blocked 1h. Frozen tissues
were homogenized on a shaker with 1.4 mm zirconium beads (Precellys, Bertin) in RIPA lysis buffer (Millipore) and lysates were
centrifuged 13,000 rpm for 5 min. Supernatants diluted 1:1 with reagent diluent, added in duplicate to coated wells along with a
granzyme B standard series and incubated at RT for 2 h. Plates were washed thoroughly before addition of Streptavidin-HRP,
followed by substrate buffer. Stop solution was applied and absorbance (450 nm minus 540 nm correction) read on a microplate
spectrophotometer (BioTek Instruments, VT, US). Granzyme B levels in samples were analyzed using the four parameter logistic
curve fitting algorithm by reference to standard curve values and performed using online software (https://elisaanalysis.com/).
Reverse transcription polymerase chain reaction (RT-PCR)
Total RNA was extracted from L5 DRG from L5x or sham mice (two mice pooled per sample) and L3-L5 DRG from sciatic crush or
shammice (onemouse per sample). Tissueswere disrupted in RTL Plus lysis buffer (QIAGEN) including 1% b-mercaptoethanol with a
mini glass mortar and pestle on ice and further homogenized using a Minilys bead homogenizer (Precellys, Bertin, France); DRG
cultures werewashed once in warmHBSS prior to lysis by pipetting; frozen cell pellets were vortexed in lysis buffer. RNAwas purified
from lysed samples, including genomic DNA elimination, by on-column extraction (RNeasy Plus, QIAGEN) according to the manu-
facturer’s instructions. RNA was eluted in RNase-free water and analyzed for purity (260/280 nm ratios of approximately 2.0 weree8 Cell 176, 716–728.e1–e10, February 7, 2019
considered acceptable) and nucleotide content on a spectrophotometer. Equal amounts of RNA (150-250 ng fromwhole DRG, 500ng
from cell cultures) was reversed-transcribed using M-MLV (200 U/rxn), dNTPs and oligo(dT)12-18 primers (Invitrogen) in a 20 ml reac-
tion volume according to the manufacturer’s instructions. PCR reactions (25 ml) using Go Taq Flexi DNA polymerase (Promega)
were then performed from cDNA on a thermal cycler (MJ Mini, BioRad) with the following primer pairs: Raet1a-e universal
primers (Raet1 alpha, GenBank: NM_009016.1; Raet1 beta, GenBank: NM_009017.1; Raet1 gamma, GenBank: NM_009018.1;
Raet1 delta, GenBank: NM_020030.2; Raet1 epsilon, GenBank: NM_198193.2) (270bp), (forward*) 50-GCTGTTGCCACAGTCA
CATC-30, (reverse) 50-CCTGGGTCACCTGAAGTCAT-30; NK1.1 (Klrb1c v1, GenBank: NM_001159904.1; Klrb1c v2, GenBank:
NM_008527.2) (277bp), (forward*) 50- GGAACAGAGCAGAGCATTCA-30, (reverse*) 50-CCAATCAGGGTCAGGACAAG-30; Advillin
(NM_009635.3) (332bp), (forward*) 50-GCTACATCGTCCTCTCGACC-30, (reverse*) 50-CATTTCCACCTCCGTGGCTT-30; Gapdh
(Gapdh v1, GenBank: NM_001289726.1; Gapdh v2, GenBank: NM_008084.3) (230bp), (forward*) 50-AACAGCAACTCCCA
CTCTTC-30, (reverse*) 50-TGGGTGCAGCGAACTTTAT-30. Asterisk (*) indicates primers which cross an exon-exon boundary. The
PCR conditions were 95C (2min), cycled 35 times from 95C (30 s) to 60C (30 s) to 72C (30 s), 72C (5min), 4C (forever). Reactions
performed without cDNA served as negative control. PCR products were run on an agarose (1.5%) gel containing a DNA staining
reagent (SafePinky, GenDepot, USA) and visualized on a UV transilluminator.
Quantitative real-time PCR
Gene expression was analysis performed on cDNA fromDRG using a Power SYBRGreen PCRMaster Mix (Applied Biosystems) and
pairs of target-specific primers (500nM) in MicroAmp optical tubes (20ml reaction volume) on a 7500 Real-Time PCR system (Applied
Biosystems). The PCR conditions were 50C (2 min), 95C (10 min), and cycled 40 times at 95C (15 s) to 60C (1 min). Samples were
run in triplicate. Data were analyzed using the built-in 7500 software (v2.0.4, Life Technologies) and expression was determined rela-
tive to a reference gene (Gapdh) in adult DRG for cultures or contralateral DRG for nerve injury experiments using the comparative Ct
method. Primers were designed using Primer-BLAST software (NIH). Primers were selected based on specificity to the desired target
gene upon BLAST search, overlap of the exon-exon boundary, lack of potential hairpin-forming or self-priming regions, single peak in
the dissociation curve (single band PCR product) and equivalent amplification efficiency (linear shift in Ct value upon serial dilution of
cDNA). Products of reverse transcription reactions omitting RNA or M-MLV (-RT) served as negative controls. Primer pairs were syn-
thesized by a commercial supplier (Bionics, Korea) with the following sequences: Raet1a-e universal primers designed to detect all
fiveRaet1 isoforms (a,b,g,d,ε) (60bp), (forward*) 50-AACGGGCTGGATGATGCAC-30, (reverse*) 50-TGGGGTAGGATCCTTGATGGT-30;
Gapdh (72bp), (forward*) 50-TCCATGACAACTTTGGCATTG-30, (reverse*) 50-CAGTCTTCTGGGTGGCAGTGA-30. Asterisk (*) indi-
cates primers which cross an exon-exon boundary.
QUANTIFICATION AND STATISTICAL ANALYSIS
Laser scanning confocal imaging and analysis
For analysis of neurite density in microfluidic co-cultures, single z section low magnification (x10) confocal images at 0.5 zoom
(LSM700, Zeiss) were acquired of b-tubulin III immunofluorescence (647nm emission) along the full length of the neurite compart-
ment. Gamma high channel images were exported as an unaltered TIFF using Zeiss imaging software (v8.1, ZEN 2012 SP1, Zeiss).
Images were converted to b/w by adjusting to a set threshold, scale calibrated and horizontal pixel density was measured using the
Plot Profile function in ImageJ (v1.46r, NIH). The distance to 50%neurite density was calculated from the normalized cumulative pixel
density. 6-8 images per were acquired per microfluidic device, n = 3 devices per group.
For analysis of neurite fragmentation in NK-DRG co-cultures, 5-10 fields of view were randomly selected from each coverslip in a
non-systematic manner for acquisition in single or double z section confocal images at low magnification (x20) and 0.5 zoom
(LSM700, Zeiss). For total neurite fragmentation gamma high channel images of b-tubulin III immunofluorescence were exported
as an unaltered TIFF. In ImageJ images were scale calibrated (1.6 pixels/mm) and brightness threshold set in b/w mode, creating
a whole neuron silhouette for selection. Neurite fragments were selected using the Analyze Particles function (size 0.5-25 mm2,
circularity 0-1) and saved as a drawing. The total area and particular area values (mm2) were obtained using the Measure function.
Total DRG cell body area was measured separately and subtracted from the total area to calculate the percent specific neurite
fragmentation for each field of view.
For analysis of b-tubulin III and STMN2 labeling in sciatic nerve tissue, a composite of the full length nerve was created from
individual z section images acquired at x10 magnification and 0.5 zoom along the length of the nerve (LSM700, Zeiss). Images con-
taining crush site, as well as proximal and distal regions (±1-2 mm from the crush site) were exported to ImageJ, scale calibrated
(0.8 pixels/mm) and brightness threshold set in b/w mode. The mean pixel density from a 9000 mm2 selection of the nerve mid-image
was recorded from 3-4 images per nerve region, per mouse, per treatment.
Co-localized regions of RAE1 double-labeling with b-tubulin III and STMN2were exported using the co-localization function on the
Zen 2012 software after setting for threshold image intensity in both fluorescence channels (1000 units per channel).
For in situ hybridization, 3x 2 mm z sections were acquired using x20 apochromat lens at 1x digital zoom. A tile scan of 1024x1024
pixels, 12 bit images was performed with 5% overlap. Image re-stitching was performed offline. Acquisition settings were set to
maximize intensity of positive control probe signal while maintaining negligible background on sections labeled with negative control
probe. Identical 405 nm and 546 nm channel settings were used throughout imaging of all sections. Images were exported asCell 176, 716–728.e1–e10, February 7, 2019 e9
maximum intensity projection TIFs for image analysis. Images were processed and analyzed in ImageJ. A 500 mm2 sample area of
each DRG section was selected and cropped. Blue channel (NeuN) images were used to guide manual selection of individual neuron
outlines, which were saved to the region of interest (ROI) manager. ROI selections were then applied to the red channel (in situ), which
was converted to an 8-bit black/white imagewith threshold set at 1-255. The number of particles per NeuN+ ROI (larger than 1 mm2 to
eliminate background spots) were counted using the Particles Analysis function in ImageJ and exported to a spreadsheet (Microsoft
Excel). A total of n = 2138NeuN+ROI from ipsilateral DRGand n = 1565NeuN+ROI from contralateral DRGwere included; n = 3mice,
n = 3 sections per DRG per mouse. Data are presented as a frequency distribution of the number of in situ spots per neuron (NeuN+
ROI), and versus neuronal cell size (mm2).
Statistical Analysis
Comparisons between two groups of data were made with Student’s t test (paired or unpaired) or Mann-Whitney test for non-normal
distributions (confirmed with Kolmogorov-Smirnov test). Comparisons between three or more groups of data were made with
One-way ANOVA. All tests are two-sided unless indicated. Two-way ANOVA tests were used to compare the effects of treatments
on molecular, cellular and behavioral assays over time. Data are presented as mean ± standard error of the mean (SEM) unless
otherwise stated. ns, not significant. Analyseswere performed usingGraphPad Prism version 5.00 forWindows, GraphPad Software,
San Diego California USA, https://www.graphpad.com/. No statistical methods were used to predetermine sample sizes, which
were based on previous literature and availability of animals. For behavior tests experimenters were blinded either to the treatment
or genotype of the mice during both surgery and sensory testing. Treatments were assigned to littermates at random by an indepen-
dent observer. p < 0.05 was considered significant.e10 Cell 176, 716–728.e1–e10, February 7, 2019
Supplemental Figures
Figure S1. Isolation, Enrichment, and Activation of NK Cells from Adult Mouse Spleen and Cytotoxicity of IL-2-Stimulated NK Cells against
Embryonic DRG Neurons, Related to Figure 1
(A) Intracellular staining of granzyme B of freshly isolated (left) and IL-2 stimulated (right) NK cells.
(B) Flow cytometry plot of splenic lymphocytes. NKp46+DX5+ NK cells (top-right quadrant) in whole spleen homogenate (left) and after MACS enrichment by
negative selection (right). NK cells require cell contact to mediate toxicity against embryonic DRG neurons.
(C) Representative immunostaining images of embryonic DRG neurons (b-tubulin III, magenta) after 4 h co-culture with IL-2 stimulated NK cells (NKp46, green)
either in direct contact or separated by a transwell membrane (0.4 mm pores).
(D) ELISA detection of granzyme B in media of NK cell-DRG co-cultures. One way ANOVA, F(2,6) = 0.7248, p = 0.5225. n = 3 experimental repeats. Granzyme B
was not detected in cultures containing unstimulated NK cells (data not shown).
(E) NKG2D receptor contributes to NK cell-mediated lysis of embryonic DRG neurons. Cytotoxicity of IL-2 stimulated NK cells against embryonic DRG
neurons after 4 h co-culture in the presence of blocking anti-NKG2D antibody or IgG control antibody. Two-way ANOVA: Effect of antibody treatment, F(1,4) =
21.21, p = 0.0100. n = 3 experimental repeats.
Figure S2. Antibody Blockade of NKG2D Receptor on NK Cells Attenuates Neurite Degeneration of Adult DRG Neurons In Vitro, Related to
Figures 2 and 3
(A) Immunolabeling (b-tubulin III) of cultured adult DRG (103 cells per coverslip) (2 days in vitro) co-cultured (4 h) with IL-2 stimulated NK cells (2.5x105 cells per
coverslip) pre-treated with either anti-NKG2D or IgG isotype control antibody.
(B) Quantification of DRG neurite fragmentation after NKG2D receptor blockade. One way ANOVA, F(3,193) = 36.82, p < 0.0001 with Bonferroni post-test, ***p <
0.001. n = 6-8 regions per coverslip, n = 4-6 coverslips per group, two independent experimental repeats.
(C) L5 DRG neurons were cultured 7 days after L5x injury (24 h in culture) and exposed to IL-2 stimulated NK cells in the presence of anti-NKG2D (CX5) blocking
antibody or IgG1k isotype control (30 mg/ml) for 4 h. Images representative of b tubulin III labeling of fixed cultures in each condition.
(D) Quantification of DRG neurite fragmentation in acute (< 24 h) cultures of L5x injured DRG neuron-NK co-cultures. One-way ANOVA; F (2,67) = 32.07, p <
0.0001 with Bonferroni post-test:: t = 7.999, t = 4.492; ***p < 0.0001; n = 6-8 regions per coverslip, n = 3 coverslips per group.
(E) Quantification of total DRG cell body area in acute (< 24 h) cultures of sham and L5x injured DRG neuron co-cultured with or without control or IL-2 stimulated
NK cells (4 h). One-way ANOVA: Sham, F(2,61) = 1.457, p = 0.2409; L5x, F(2,56) = 1.559, p = 0.2194. Bonferroni post-tests: ns, p > 0.05. n = 6-8 regions per
coverslip, n = 3-6 coverslips per group, two independent experiments.
Figure S3. Characterization of NKp46-cre Mice, Related to Figures 3 and 4
(A) Flow cytometry of peripheral blood lymphocytes from NKp46-YFP mice labeled with anti-NKp46 and anti-CD3 antibodies.
(B) Immunolabeling with an anti-GFP antibody (green) in spleen tissue sections from wild-type and NKp46-YFP mice. Note enhancement of signal only in labeled
NKp46-YFP mouse spleen tissue.
(C) Flow cytometry of peripheral blood lymphocytes from NKp46-DTR or wild-type (WT) mice 24 h after intravenous treatment with DTx (100 ng) or PBS vehicle
(100 ml). Cells labeled with fluorescent-conjugated anti-NKp46 and anti-CD3 antibodies.
(D) NKp46-DTR mice were chronically treated with DTx (n = 11) or PBS vehicle (n = 11) (i.v.) followed by L5 spinal nerve transection surgery (Day 0). Sensitivity to
mechanical (von Frey filament) stimulation in the injured ipsilateral hind paw before (naive) and after injections (baseline) and at intervals after L5x injury. Ipsilateral:
Two-way ANOVA (effect of time) F(6,140) = 62.24, #p < 0.0001; (effect of depletion) F(1,140) = 1.13, p = 0.2894 (ns, not significant).
(E) Uninjured contralateral hind paw. Two-way ANOVA (effect of time) F(6,140) = 0.58, p = 0.7468; (effect of depletion) F(1,140) = 0.11, p = 0.7174.
Figure S4. Injury-Dependent Regulation of Raet1 mRNA and RAE1 Protein Expression in Sensory Neurons In Vivo, Related to Figure 4
(A) The size of all NeuN+ neuronal profiles in each DRG are shown as a histograms in blue (50 mm2 bins). The number of in situ ‘spots’ per NeuN+ neuronal profile
are overlayed as a scatterplot. The majority of de novo Raet1-expressing NeuN+ profiles in ipsilateral DRG appear to be in the small-medium size range
(200-500 mm2). A large number ofRaet1 in situ spots are also seen NeuN+ profiles of 500 mm2 and greater in ipsilateral DRG. The overall size distribution of NeuN+
profiles was not different between DRG (Kolmogorov-Smirnov test: p = 0.0513, KS D-value = 0.04502).
(B) Maximum projection images of RAE1 (green) co-localized with neuronal injury marker STMN2 (magenta) in sciatic nerve 3 days after tight ligation. Note lack of
STMN2 immunolabeling in uninjured contralateral nerves. Scale bars, 50 mm.
(C) western blots of ligated and proximal regions of sciatic nerve tissue 7 days after tight ligation (35 mg protein loading) with pan-RAE1 antibody and neuronal
cadherin as loading controls. Blots from two independent experiments.
(legend on next page)
Figure S5. Systemic NK Cell Depletion Prevents Sensory Loss after Sciatic Nerve Crush, Related to Figure 5
(A) Sciatic nerve tissue sections from adult male NKp46-YFP mice 7 days after sciatic nerve crush injury. Inset shows higher magnification of ipsilateral nerve.
Arrows indicate co-localization of NKp46-YFP (anti-GFP, green) and nuclear (DAPI, blue) labeling.
(B) Flow cytometry scatterplots of sciatic nerve homogenates obtained from an NKp46-YFP mouse 3 days after sciatic nerve crush injury.
(C) Quantification of total number of CD45+/YFP+ double-positive events within lymphocyte FSC/SSC gate from whole sciatic nerve homogenates. Two-way
ANOVA, Crush: Effect of injury, F(1,16) = 168.63, p < 0.0001; Effect of time, F(1,16) = 8.10, p = 0.0117. Bonferroni post-test: 3 days ipsi versus contra crush,
t = 7.426, ***p < 0.001; 7 days ipsi versus contra crush, t = 10.94, ***p < 0.001 (n = 5 mice per time point).
(D) ELISA quantification of granzyme B content in whole sciatic nerve 7 days after crush injury in wild-type mice. ipsi versus contra, t = 7.112 (paired one-tailed
t test, n = 8 mice);
(E) NKp46+/DX5+ double-positive lymphocytes in peripheral blood 16 days after sciatic nerve crush. Student’s unpaired t test: t = 8.012, p < 0.0001.
(F) NKp46 immunolabeling and nuclear (DAPI) staining in sciatic nerve sections (14 mm) 7 days after forceps crush injury in NKp46-DTR mice treated with DTx or
PBS vehicle.
(G) Quantification of NKp46+DAPI+ cells (white arrows) within a 0.4 mm2 region of the nerve crush site were counted by an investigator blind to the treatment.
Student’s unpaired t test, t = 2.898, p = 0.0442. n = 2-3 sections per nerve, n = 3 mice per treatment.
(H) ELISA quantification of granzyme B content in whole sciatic nerve 7 days after crush injury in NKp46-DTR mice after treatment with PBS or DTx. t = 2.024
(unpaired one-tailed t test, n = 4 mice per treatment).
(I) Daily pinprick response score in NKp46-DTR mice treated intravenously with DTx or PBS vehicle every 4 to 5 days. Full sciatic nerve crush on day 0. Two-way
ANOVA: Effect of depletion, F(1,352) = 25.20, p < 0.0001). n = 12 mice per group. Bonferroni post-test, *p < 0.05 (t = 3.048).
(J) Heatmap showing mean sensitivity to pinprick along the lateral hind paw.
(K) Peripheral blood sampled 16 days post-injury shows almost a complete loss of NKp46+DX5+ NK cells in DTx-treated NKp46-DTR mice compared to wild-
type. Student’s unpaired t tests., t = 7.761, p < 0.0001.
(L) CD3+CD8+ (t = 0.8590, p = 0.4030) and CD3+CD4+ (t = 1.971, p = 0.0662) T cell populations were not different between genotypes after DTx treatment
(Student’s unpaired t tests).
(M) 8 wild-type and 10 NKp46-DTR mice received partial crush of the sciatic nerve on day 0 as well as diphtheria toxin (DTx) i.v. starting one day before surgery
and continuing every 4 to 5 days. All mice were treated with IL-2/anti-IL-2 antibody complex i.p. daily for four consecutive days from the evening of day 2 (arrows).
Daily pinprick response shows a transient reduction in sensitivity in wild-type mice receiving the IL-2/anti-IL-2 antibody complex and DTx treatment but not
NKp46-DTR mice. Two-way ANOVA. Effect of genotype: F(1,275) = 12.49, p = 0.0005). Bonferroni post-test, **p < 0.01 (t = 3.789).
(N) Heatmap showing mean sensitivity to pinprick along the lateral hind paw.
Figure S6. NKG2D Antibody Block Attenuates Effect of IL-2 Complex Treatment on Sensory Recovery after Partial Sciatic Nerve Crush,
Related to Figure 6
(A) Adult male C57BL/6 mice received a total of 200 mg anti-mouse NKG2D (CX5 clone) (n = 3) or IgG1k isotype control (n = 3) via retroorbital injection (i.v.) over
4 days (Ogasawara et al., 2004): 50 mg (Day 0), 50 mg (Day 2), 100 mg (Day 4). One day later (Day 5) PBMCs were isolated and labeled with PE-conjugated anti-
mouse NKG2D or isotype controls, as well as cell surface NK cell markers NKp46 and DX5. Flow cytometry data were gated on NKp46+DX5+ lymphocytes from
70,000 events.
(B) Histogram of NKG2D-PE fluorescence labeling on NKP46+DX5+ gated lymphocytes relative to isotype-PE controls (gray filled). Blue, IgG1k isotype control
injection; Red, NKG2D blocking antibody injection.
(C) Quantification of mean NKG2D immunofluorescence (IgG isotype subtracted) in NKp46+DX5+ cell population. Student’s t test, t = 9.763, p = 0.0006; n = 3
mice per treatment.
(D) Daily pinprick responses in wild-type mice which received either blocking anti-NKG2D antibody (n = 12) or IgGk1 isotype control (n = 7) on days 0, 2 and 4
following partial (moderate) crush of the sciatic nerve. All mice were treated with IL-2/anti-IL-2 antibody complex i.p. daily for four consecutive days from the
evening of day 2 (arrows). Two-way ANOVA. Effect of antibody: F(1,187) = 8.03, **p = 0.0051).
(E) Area under the curve measurements. Days 1-4: t = 0.1739, p = 0.8640; Days 5-10: t = 2.13, p = 0.0451; Days 11-15: t = 1.059, p = 0.3044. Student’s unpaired
t test.
(F) Mechanical sensitivity thresholds of ipsilateral (injured: U = 12.00 p = 0.0122, Mann-Whitney U test) and contralateral (uninjured: U = 39.00, p = 0.8303,
Mann-Whitney U test) hind paw 16 days after partial crush injury.
Figure S7. Specific Overexpression ofRaet1 in Nociceptive (TrpV1-Expressing) Neurons Reduces Sensitivity to Noxious Heat but Not Touch,
Related to Figure 7
(A) qPCR shows increase in Raet1 mRNA expression in DRG from TrpV1-Rae1 mice. One-way ANOVA; F (2,18) = 9.346; p = 0.0016 with Bonferroni post-test,
t = 3.885, **p < 0.01. n = 5 (C57BL/6), 8 (littermates and TrpV1-Rae1 mice).
(B) Latency to withdrawal from a 49C hotplate. Cut-off time was set at 60 s. TrpV1-Rae1 mice showed reduction on heat pain perception compare to littermate
controls. One-way ANOVA; F (2,21) = 22.31; p < 0.0001 with Bonferroni post-test, t = 4.831, ***p < 0.001). n = 8 mice per genotype.
(C) TrpV1-Rae1 mice did not differ from littermate or wild-type controls in their mechanical sensitivity, as measured by the 50% threshold with von Frey filaments
of different forces applied to the plantar surface of the hind paw. One-way ANOVA; n = 8 mice per genotype (ns, not significant).
